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INTRODUCTION

INTRODUCTION
I. General background
Since the introduction of antimicrobial agents an increase in the prevalence of
antibiotic-resistant microorganisms has been observed. In the pre-antibiotic era pathogenic
bacteria of medical importance generally showed a lower prevalence of antibiotic resis-
tance than after the introduction and (extensive) use of antibiotics. In 1940, for example,
nearly all 5/a/7/i>/ococcus aurms isolates were susceptible to penicillin, at present more
than 80% of hospital as well as extramural isolates are penicillin-resistant.
To describe the extent of the problem of antibiotic resistance it is convenient to
consider the hospital and the community as two separate ecosystems, different among
aspects in populations, selective pressures and reservoirs and each with a characteristic
pattern of emergence, prevalence and transmission of antibiotic-resistant microorganisms.
However, the ecosystems are not completely isolated from each other as an exchange of
antibiotic resistance genes and antibiotic-resistant microorganisms does take place. Both
ecosystems have in common an increasing problem of antibiotic resistance among
microorganisms, which may have serious consequences for public health.
The impact of the emerging antimicrobial resistance on health care can be
summarized as follows: First, treatment failure in infections caused by resistant microor-
ganisms treated with what is considered an appropriate empirical therapy. This leads to an
increased morbidity and mortality and an increase in health care costs. Second, antibiotic
resistance is sometimes encoded on plasmids that also encode for virulence factors. This
phenomenon of "indirect selection" will therefore result in more severe infections with a
higher morbidity and mortality as compared to those infections caused by susceptible
microorganisms. Third, treatment of an infected person with an antibiotic to which the
causative microorganism is resistant will provide a selective advantage for this resistant
microorganism since in many cases the susceptible bacteria of the patient's own micro-
flora will be eradicated. This results in a longer period of persistence of the resistant
microorganisms in the host.
Finally, an essential part of the infection-prevention strategy for communicable
diseases is effective eradication of the source. Persons who have infections and who are
inadequately treated because of antibiotic resistance will therefore remain a potential
source for a longer period of time.
It is generally accepted that antimicrobial usage relates to the emergence, persist-
ence and dissemination of antibiotic-resistant microorganisms. However, a direct causal
relationship between antibiotic usage and emergence of resistance is sometimes difficult to
prove. Some authors have described this phenomenon in a single hospital with a single
specific antibiotic. Other cofactors that contribute to or exert an influence on the selection
of the bacteria are the presence of an environmental or human reservoir, the socio-
economic circumstances and the characteristics of the microorganisms.
The presence in nature of dense bacterial populations, e.g. the human gut flora,
can be considered as ecological niches in which a large reservoir of genetic material,
including resistance genes, is maintained, continuously introduced, and exchanged.
Among the socio-economic circumstances that contribute to the resistance problem are the
increase in numbers of elderly and immunocompromised patients in the population,
resulting in an increased risk of infection and the usage of antimicrobial agents. This, in
turn, increases the chance for the spread of resistant microorganisms. Also crowding and
malnutrition are well known factors that contribute to the persistance and transmission of
infectious diseases. The characteristics of the microorganisms concerned include their
intrinsic resistance, their ability to survive adverse environmental conditions, their
capacity to colonize and infect susceptible hosts and their capacity to exchange genetic
material.
Several strategies have been developed in order to reduce the risk of emergence,
persistence and spread of antibiotic-resistant microorganisms. Among these, the effort to
reduce the inappropriate use of antibiotics in humans and in animals is by far the most
important one. Relevant and up to date information on antibiotic resistance patterns of
medically important bacterial species is an important tool for guiding the empirical choice
of antibiotics and for improving appropriate therapy. Active population-based surveillance
on a national and an international level is necessary to provide these data.
In this context, the present study was performed to look into several aspects of
antibiotic resistance in the non-hospital environment and the results are described in this
thesis.
II. Outline of the thesis
In chapter I relevant literature is reviewed concerning the prevalence of antibiotic
resistance in several human populations that differ in their exposure to risk factors for the
emergence of resistance and selection of resistant strains. Especially, the available data in
several groups of healthy humans, i.e. pig farmers, abattoir workers, (sub)urban resi-
dents, and general practice patients, the mechanisms of bacterial resistance and the effect
of antimicrobial therapy on antibiotic resistance are emphazised.
Chapter II, entitled 'Resistance in faecal &c/ieric/w'a co//' isolated from pigfarmers
and abattoir workers' describes the prevalence and degree of antibiotic resistance of faecal
Erc^eric/i/a co// isolated from pig farmers and abattoir workers as compared to a control
group of (sub)urban residents.
The variation in prevalence and degree of antibiotic resistance and the reproduci-
bility of sampling over time in a certain group of healthy people was the subject of the
study presented in chapter III, entitled 'Antibiotic resistance of faecal Enterobacteriaceae
isolated from healthy volunteers, a 15-week follow-up study*.
Chapter IV, entitled 'Carriage of antibiotic-resistant Esc/ieric/i/fl eoff by healthy
volunteers during a 15-week period' presents the results of the study of the antibiotic sus-
ceptibilities of Esc/ien'c/i/a co/i strains isolated from healthy volunteers with special
emphasis on the variation in antibiotic resistance patterns over a 15-week period. In
addition, the mechanism of high level trimethoprim resistance (i.e. MIC S 1024 mg/1) is
characterized with probes specifying type I and type V mediated resistance.
The effect of amoxycillin or doxycycline therapy on the antibiotic resistance of
faecal £rc/icricA/a co/i isolated from general practice patients treated for a respiratory
tract infection is presented in chapter V, entitled 'Effect of antibiotic therapy on the
antibiotic resistance of faecal Esdieridi/a co/i in patients attending general practitioners'.
Chapter VI, entitled 'Comparison of virulence factors of urinary and faecal
£rc/iericW<j co/i isolated from the same patient" presents the results of the study in which
faecal and urinary Erdieridi/a co// isolated from patients with an uncomplicated urinary
tract infection from general practice were compared with respect to virulence factors,
serotype and antibiotic susceptibility in order to determine the role of the faecal flora as a
reservoir for uropathogens.
Chapter VII, entitled 'A piperacillin-tazobactam resistant ErcAericWa co// strain
isolated from a faecal sample of a healthy volunteer', describes the mechanism of a TEM-
1 "like" producing fijc/ier/c/wa co// strain resistant to the combination of piperacillin and
the B-lactamase inhibitor tazobactam.
In chapter VIII the results of the studies presented are reviewed, discussed and
conclusions and recommendations are formulated.
CHAPTER I
REVIEW OF THE LITERATURE
&
AIMS OF THE STUDY

Antibiotic resistance
Nowadays bacterial resistance to antimicrobial agents is an important obstacle for
the successful treatment of bacterial infections, leading not only to treatment failures but
consequently to prolonged morbidity and even mortality [40,58,59,60]. Since the
introduction of antimicrobial agents into clinical practice, microorganisms have been
labelled sensitive or resistant. In clinical practice "resistance" means that an infection
caused by an antibiotic-resistant microorganism of a normally sensitive species cannot be
treated successfully with that particular agent using standard dosages. For microbiologists,
resistance means that an antimicrobial agent, even used in higher doses, has little or no
effect on a particular microorganism or that an isolate has become less susceptible to an
antimicrobial agent while other bacteria of the same species still remain susceptible
[5,26].
In considering the problems caused by antibiotic-resistant bacteria it is usually the
emergence of resistance in previously susceptible bacteria that is of concern and not the
intrinsically resistant microorganisms. Lack of susceptibility (also called natural or
intrinsic resistance) is species-restricted; this means that an antimicrobial agent cannot
reach its target or binding site or because these sites are absent in the species involved.
For example Enterobacteriaceae are intrinsically resistant to benzylpenicillin, because
penicillin cannot penetrate the outer membrane of these Gram-negative bacteria. Therefo-
re this compound cannot be used for the treatment of EscAeric/i/a co// infections
[26,70,73].
There are three ways for a microorganism to become resistant to an antimicrobial
agent. First, selection. Even before the introduction of an agent a few strains are already
found to be resistant. The classic example of this type of resistance is S/a/tfjy/ococcjtf
aureus and penicillin [17]. Second, resistance due to chromosomal mutations. The
frequency of these spontaneous mutations is not influenced by exposure to antimicrobial
agents unless these agents are mutagens. Such mutations usually involve the genes
encoding the target site of the agent, or cell structures affecting access of the agent to the
target site. This kind of resistance is not transferable to other species, but only vertically
transferred to the next generation of the microorganism involved. If this spontaneous
mutation frequency is high enough, use of the antimicrobial agent will select for resistant
strains which will then replace the sensitive bacterial population. However, in the absence
of that agent these resistant strains have no particular survival advantage and mostly
disappear sooner or later [22,40,58,69,70,73]. The third kind of antibiotic resistance is
transferable resistance. The genes responsible for this kind of resistance, the so-called
resistance factors (R-factors) are mainly located on extrachromosomal circular elements of
DNA: plasmids. R-plasmids can transfer themselves from one bacterial cell to another by
conjugation, i.e. conjugative plasmids. Transfer of this type of resistance occurs not only
between bacteria belonging to the same species but also between bacteria of different
species. In addition to conjugative plasmids, bacteria may possess transposons, the so-
called "jumping genes", which are usually small pieces of DNA. Unlike plasmids, trans-
posons do not rely on a particular host cell or any particular host DNA in order to exist
or multiply. Transposons can "jump ship" on to the host chromosome or on to a resident
plasmid already stably present in the bacterial cell and while the new host may lose the
plasmid and even its copy, the transposon will remain with the new cell since it has found
a stable place in the new host. Other possible mechanisms for transferring resistance
genes include transformation and transduction. Transformation involves the pickup by a
recipient bacterial cell of pieces of naked DNA released after death by the donor bacteria.
Once taken up, the DNA can become part of the DNA of the recipient cell if donor and
recipient belong to the same species. Transduction is the process by which genes , both
from plasmid(s) or from their chromosome, are transferred to a new host via bacterial
viruses called bacteriophages. Phages infect only those bacterial hosts that have a
particular membrane site to which they can attach. Once there, the phage injects its DNA
into the bacterial cell and gene exchange can take place as soon as the phage and its DNA
piece integrate into a second host's chromosome of a bacterial cell of the same species.
The most common way of transferring resistance in v/vo in Gram-positive as well
as in Gram-negative bacteria, however, is by plasmid-mediated conjugation [32]. In
contrast to chromosomally-mediated antibiotic resistance, plasmid-mediated resistance to
one or several antibiotics, once acquired, may remain in the environment for prolonged
periods, even in the absence of selection by exposure to that antibiotic. This is because
the resistance factors are often linked to plasmids encoding for other virulence factors
and/or to resistance to other antibiotics, so-called multiple antibiotic resistance [41,70].
Multiple resistance occurs when genes conferring resistance to several unrelated antimi-
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crobial agents are linked together into one plasmid and are transferred from one bacterial
cell to another. Use of one agent will not only select for an increase of resistance to that
agent but to the other agents as well. In 1959, Japanese workers showed that multiple
resistance , in this case resistance to chloramphenicol, tetracycline, streptomycin and
sulphonamides, was transmissible from shigellae to Eic/iericJua co// [56]. In a nosocomial
outbreak among children in Mexico City, the SWge//a rfyjen/eriae involved was not only
resistant to chloramphenicol, tetracycline, streptomycin and sulphonamides but the
microorganism had also acquired resistance to ampicillin [56]. Since that time many
additional outbreaks due to multiply resistant pathogens have been recognized and
documented all over the world.
Mechanisms of antibiotic resistance
Microorganisms can become resistant to antibiotics in a number of ways. The most
common mechanism is inactivation of the antimicrobial agent. An example of this is the
hydrolysis of B-lactam antibiotics by fi-lactamases [74]. By far the most common of the
plasmid-mediated B-lactamases is TEM-1 [75]. To overcome the action of these enzymes,
B-lactamase inhibitors such as clavulanic acid and tazobactam have been developed [76].
Other mechanisms of resistance include alteration of the antibiotic target or binding site
[2], reduction in bacterial accumulation of the agent involving active efflux of the agent
out of the bacterial cell or reduced penetration of the agent into the cell due to alterations
in outer membrane proteins (OMPs) [10,12], development of a separate metabolic
pathway that allows bypassing of the target metabolic process of the antibiotic [8], altera-
tion of a molecule so that it does not effectively bind to its receptor site [18], elimination
or reduction of the requirement for a metabolite [37], or elimination of enzymes whose
action stimulated by the substance resulted in destruction of the bacteria [30].
Antibiotic use and antibiotic resistance
It is generally accepted that antibiotic resistance is related to the frequency and
amount of usage of that particular agent in a certain population [50,65]. Several studies in
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humans dealing with the relation between antibiotic consumption and antibiotic resistance
have been performed in hospitals and describe a positive correlation between usage and
resistance [11,33,55]. In contrast, other studies have either failed to observe any relation-
ship between usage and resistance [31,34] or have shown a decrease in resistance despite
an increase in usage of a particular agent [55].
Apart from antibiotic use in humans, both in general practice and in hospitals,
veterinary and agricultural usage of antibiotics may also be partly responsible for the
increase in resistant bacteria, but it is still not clear whether antibiotic use in humans or in
animals has contributed most to the environmental pool of resistant microorganisms [44].
Just as is the case with humans, animals receive antibiotics prescribed by veterinary
surgeons therapeutically and prophylactically. However, quantitatively much more antibio-
tic is used in agriculture for crop protection and given to animals in small subtherapeutic
levels as growth promotors [5,41].
Concern for the public health implications of indiscriminate antibiotic use in
animals resulted in the Swann Report (1969) in Great Britain and an Interim Report of a
Food and Drug Administration Task Force (1972) in the USA. Both reports recommended
that antimicrobials agents be excluded from animal feed as growth promoter if these
antibiotics were also used as therapeutic agents in human or animal medicine (i.e.,
penicillins or tetracyclines) or if they were associated with the development of cross-
resistance to drugs that were registered for use in humans [23]. However, although the
recommendations of these reports have been implemented in the member states of the
European Union, they have not yet been implemented in the USA.
In human medicine, resistance to antimicrobial agents is mainly a problem in
hospitals, in which large quantities of antibiotics are frequently used for treating infec-
tions. As in the hospital environment new microorganisms are constantly being introduced
from new patients and personnel, this setting most probably represents the greatest
reservoir of significant resistant bacteria [32]. The heavy use of antibiotics exerts a selec-
tive pressure on these resistant microorganisms which may consequently accumulate in the
hospital and may be spread to the open population as soon as the patients are discharged
back to the community [14,70].
The prevalence of antibiotic-resistant microorganisms in general practice patients
and the spread of these resistant strains in that population are less well documented
[25,72,77,78]. General practitioners prescribe most antimicrobial agents for the treatment
of urinary tract infections or respiratory tract infections [24]. The choice of antibiotic is
usually made and treatment started on an educated guess before laboratory data on the
susceptibility of the causative organism are available. For an educated guess and an
optimal antibiotic therapy knowledge of the probable infecting organism and its likely sus-
ceptibility is essential [71].
The prevalence of antibiotic resistance in clinical isolates might be considered as
the top of the iceberg as the usage of antibiotics also selects for antibiotic-resistant strains
in the human gut flora. Several studies have analysed the effect of antimicrobial therapy
on selection of antibiotic-resistant microorganisms in the faecal flora [1,64]. Therapeutic
oral courses of ampicillin or a sulphonamide had only slight effect in selection of faecal
Esc/ieridw'a co/i resistant to that particular agent [15]. Similar observations were made
after use of trimethoprim or co-trimoxazole [36], but tetracycline, a broad spectrum
antibiotic, exerted strong selection, not only for tetracycline resistance but also for resis-
tance to ampicillin, streptomycin, chloramphenicol and sulphonamides [15].
Another aspect of the problem of antibiotic resistance is the contamination and
possible colonization of the human gut with resistant microorganisms from an exogenous
source. Colonization or even transit of the human gut with exogenous resistant microor-
ganisms seems to be an important factor for the introduction of new resistant genes into
commensal microorganisms and into (potentially) pathogenic microorganisms [5,70].
Some studies described the colonization of the human gut with antibiotic-resistant animal
isolates [29,41]. However, other studies suggest that under certain circumstances £i-
c/ienc/i/a co/i strains carrying R-factors may not be such good colonizers as those that are
drug-sensitive [4] and that it is very difficult to prove that the £jc/ien'c/i/a coW strains
colonizing the human gut are indeed the same as those found in animals [48].
If R-factors of colonizing resistant Ejc/ieridwa co/i are transferred to pathogens
such as Sa/moneZ/a spp. or ye/sima spp. the chance of infection after eating a product
contaminated with these pathogens is higher in people taking antibiotics to which the
microorganism is resistant. In the USA Sa//nonW/a neuron caused serious disease in 18
persons, of whom 12 had taken antibiotics recently for other reasons. All of them had
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prepared and eaten minced beef (hamburger) in the week before illness. It was found that
the meat used for the hamburgers was obtained from beef cattle which had been fed
subtherapeutic doses of chlortetracycline. It seemed very likely that the resistant strain
had a selective survival advantage in the antibiotic-treated people [29]. The importance of
person-to-person spread [9] and food-borne illness resulting from contamination of foods
with Sa/monW/a spp. transmitted by human carriers must be considered along with animal
sources [23].
Reservoirs of antibiotic-resistant Escfcerzc/iuj cob'
The intestinal flora is considered the main reservoir of antibiotic-resistant
Ercferidi/a co// and antibiotic resistance genes in the population as well as in hospitals
[20,28,35,38,43,51,66].
The bacterial flora of hospitalized patients consists of bacterial strains which they brought
with them to the hospital, i.e. the flora of the community, plus the microorganisms acqui-
red in the hospital, i.e. the nosocomial flora [62]. In the early years of the antibiotic era,
Gram-positive cocci (5;repwcocci« pvogener, S/re/tfococotf pnewno/i/ae, and 5fop/iv/o-
coccus aureuj) were the most common causes of hospital infections. More recently they
have been replaced by facultatively anaerobic Gram-negative bacilli and multi-resistant
fjcurfomo/wu aeruginasfl strains as the most important cause of nosocomial infections
[52]. Nowadays, however, the importance of Gram-positive cocci is again increasing.
When patients leave the hospital, the resistant microorganisms can be transferred to
people in the population either directly, e.g. by close contact, or indirectly, e.g. by food
handling [13,16].
To reduce the chance of emergence of resistance often combinations of antimicro-
bial agents are used, such as a cephalosporin or broad-spectrum penicillin plus an
aminoglycoside [53]. The improved hygienic practices in the hospital to avoid the spread
of multi-resistant strains from patient to patient seem to be effective. Also an understand-
ing of resistance mechanisms will assist the clinician in the rational and appropriate use of
antibiotics [73].
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Antibiotic resistance in animals: an additional reservoir
As the environments of animals and humans are not separate, exchange of bacteria
and bacterial genes occurs between both groups. The indirect effects caused by the use of
antibiotics in animals on the acquisition of antibiotic-resistant bacteria affecting humans
include the possible transfer of resistant bacterial strains and R-factors from animal to
man. The transfer of bacterial strains can take place after direct contact with the animal,
after contact with animal faeces or contaminated animal carcasses as is the case by
farmers, abattoir workers or butchers or following the preparation and ingestion of conta-
minated meat. Levy ef fl/. demonstrated cross infection of Esc/iericWa co// from chickens
to the humans in contact with the birds. The EsdiericMa co/i strain involved was marked
by a temperature-sensitive chloramphenicol-resistance [39]. Transfer of R-factors between
man and domestic pets can also occur and is likely to take place since the contact between
owner and pet is often very close [19]. It is to be expected that people having close con-
tacts with pigs or pig carcasses have a greater risk of becoming contaminated with animal
intestinal bacteria which might harbour R-plasmids than people without or with less
contact. Abattoir workers are in close contact with pig carcasses contaminated with gut
contents following slaughter [46] and pig farmers also have close and regular contact with
their animals and waste [63,79]. Direct contact with antibiotics used for treatment of pigs
and with their antibiotic-enriched feed is another possible risk factor for selection of resis-
tant strains in the intestinal flora of pig farmers [61,63]. As the number of people having
direct contact with food animals (cattle, pigs, poultry) is relatively small, it is very likely
that the effect on the population is of minor importance. Consequently this route of cross-
infection is only important for individuals [48]. The main route by which resistant
Erc/ieric/iitf co/i and resistant genes pass to the human population from outside is via the
food chain: slaughter, packaging, distribution, handling raw meat, cooking, and eating
[47,48,49,68].
Prevalence of antibiotic-resistant EscAencAui coff in developing countries
The prevalence of antimicrobial resistance in the healthy human population is often
higher in developing countries than in developed ones. In developing countries antibiotics
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are available over the counter, without prescription. Even the antimicrobial agents which
are easy and inexpensive to obtain, but which are no longer effective because of common
resistance, are still continuously used. Since the bacteria involved are often multiresistant,
use of one antibiotic will select for the same multi-resistant strain and perhaps coupled
with poor hygiene and daily ingestion of high numbers of faecal bacteria in contaminated
water supplies, the high prevalence percentages of resistance will be maintained in those
countries [3,38,44,51,66,67]. The extensive reservoirs of resistance genes in commensal
bacteria from developing countries may also serve to introduce resistance genes into the
bacterial populations of developed countries [3]. In a study of travellers to Mexico from
the USA, 57% of those who had no trimethoprim-resistant £rcAeric/»'a co// in their
commensal faecal flora on entering the country had nevertheless acquired them on return
[57], The major problem of antibiotic resistance in developed countries is caused by
indiscriminate and excessive consumption of antibiotics.
Prevalence of antibiotic-resistant Esc/ieric/iia co/i in developed countries
Relatively little is known about the prevalence of antibiotic-resistant bacteria in the
healthy human population not subjected to antimicrobial chemotherapy or prophylaxis.
In Dublin, faecal £rc/ieridiia a>// strains from healthy infants were examined for antibio-
tic resistance [54]. In 81 out of a total of 100 faecal samples antibiotic-resistant strains
were isolated; resistance to ampicillin was found in 62%, and to streptomycin and
tetracycline resistance in 63% and 67%, respectively. Eighty-four percent of these 81
strains were shown to possess R-factors. Only a low correlation between previous
antibacterial therapy and antibiotic-resistant enterobacteria was found, i.e. 7 (39%) of 18
infants who had received either penicillin or ampicillin recently had a predominantly
ampicillin-resistant bacterial flora [54].
Similarly, Datta (1969) examined faecal samples collected from patients before
admission to hospital for elective surgery and found that 52% contained antibiotic-
resistant Erc/ieridi/a co//\ Resistance to sulphamethoxazole and tetracycline occurred most
frequently, i.e. 38% and 34%, respectively. Resistance to streptomycin and ampicillin
was found in 27% and 17% of the patients, respectively [14].
A significant difference in the prevalence of antibiotic-resistant strains was found
Review o/rie //r
between children and adults, in both rural and urban groups in the study of Linton « a/.
(1972). For the children in the urban group the prevalence of resistance was 64%, for the
rural group even higher(73%) although not significantly. For the adults the figures were
42% and 49%, respectively. In addition, in the rural group 63% of faeces from adults of
farming families contained resistant coliform bacilli compared with a significantly lower
proportion (29%) of adults in non-farming rural families. Overall 61% of the antibiotic
resistance was transferable; ampicillin, tetracycline, streptomycin and sulphamethoxazole
resistance alone or in various combinations was transferred most frequently [45].
Levy «/ a/. (1988) found a significantly higher prevalence of resistance to
ampicillin for hospitalized patients than for healthy individuals; all of the latter were
known not to be taking antibiotics. This group consisted of laboratory workers, as well as
urban and rural dwellers. No significant differences in prevalence of resistance to any of
the antibiotics tested were found among the subpopulations of the ambulatory group,
although the general trend was towards lower numbers of resistant bacteria in the rural
samples. Eight to nine years later, in 1987, the urban group was again studied and
yielded similar results for the prevalences of resistance; also the high degrees of resistan-
ce ( a 50% of the faecal flora resistant) were of the same order of magnitude as in the
previous study: 11.3% for ampicillin, 17.5% for streptomycin, 21.3% for tetracycline,
and 7.5% for kanamycin [43].
Prevalence of antibiotic-resistant EscAericfiw co/i in the Netherlands
In the Netherlands only limited data are available on the prevalence of antibiotic
resistance in healthy people [6,7,20,21,27].
In the study of Guinee « c/. (1970) the prevalence of Erdieric/i/a co// carrying R-
factors was examined in meat-consuming individuals (military kitchen personnel and
office employees) and in those not consuming meat (vegetarians and babies below the age
of 6 months). Of the office employees, 38% yielded tetracycline-resistant ErctericAia
co//; 22% yielded one or more EsdiericA/a co// strains with transferable resistance. For
the adult vegetarians the respective figures were 52% and 27%, and for the babies 49%
and 31%. It was assumed that these babies had acquired the resistant organisms from
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their mothers. The percentages found for the vegetarians were higher than those found for
the non vegetarians; so the most important mechanism with regard to the incidence of
resistant £jc/ieric/i/a co// in man in this study was not likely to have been due to the
human consumption of meat containing antibiotic-resistant £jc/iencA/'a co// [27]. Raw
vegetables and salads often carry large numbers of resistant bacteria due to the use of
antibiotics in agriculture [42].
Degener « a/. (1978-1980 and 1987) determined the faecal carriage rates for
antibiotic-resistant Erc/ieWc/i/a co// in an urban population in Zoetermeer, a new town in
the West of the Netherlands. In the period 1978-1980 the prevalence of resistance to
ampicillin was 25%, for tetracycline 42% and sulphamethoxazole 45%. In 1987 these
percentages were 27%, 20% and 46%, respectively. The high degree of resistance, i.e.
& 50% of the faecal Esdieridi/'a co// flora in one individual being resistant, increased
from 5% to 11% for ampicillin, decreased from 12% to 6% for tetracycline and remained
almost the same for sulphamethoxazole.i.e. 19% and 21% [20,21].
In a more recently performed study of Bonten « a/. (1990) the antibiotic resis-
tance level of Esdieridj/a co// isolated from faecal samples from 172 students in
Maastricht, a city in the South of the Netherlands, was determined. In 165 out of 172
samples resistance to either ampicillin, tetracycline, sulphamethoxazole, trimethoprim or
nitrofurantoin was observed. The highest percentages were found for sulphamethoxazole
(86%), ampicillin (76%) and tetracycline (47%). For ampicillin the high degree of
resistance was 8%, for tetracycline and sulphamethoxazole 11% and 37% were found [6].
Comparison of the data of these studies on the healthy population not using any
antibiotics is difficult because of differences in methods and in selective antibiotic concen-
trations used as well as in the populations studied. Furthermore, except for the study of
Levy e/ a/. (1988), who analysed two faecal samples from the same individual and found
that 90% of all individuals showed a gain (47.6%) and/or loss (65.7%) of one or more
detectable resistances [43], data from other studies were based upon only one faecal
sample per individual. There are thus no data on the reproducibility of sampling, or on
the intra-(or within) individual variation regarding the presence of antibiotic resistance in
faecal isolates and possible changes in resistance over time.
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AIMS OF THE STUDY
With respect to the literature as discussed in this chapter several questions concerning the
prevalence of antibiotic resistance in non-hospitalized patients still remain unanswered.
The present study has been designed to answer the following questions;
I The prevalence of resistance to antimicrobial agents and the antibiotic
resistance patterns of faecal EnrAeridua co// isolated from healthy volun-
teers, i.e. pig farmers, abattoir workers and (sub)urban residents. In the
last group special attention has been paid to the reproducibility of sampling
and the intra-individual variation over time.
II The effect of antibiotic therapy on antibiotic resistance of faecal £sc/»e-
ricWa co// in general practice patients with respiratory tract infections.
III To provide evidence for the reservoir function of the faecal Esdieric/i/a
co//° flora as uropathogens.
IV To determine the mechanism of resistance to the combination of a B-lactam
antibiotic and a new B-lactamase inhibitor in an isolate from a healthy
individual who had not undergone any antibiotic therapy in the previous
three months.
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Chapter 7/
SUMMARY
Faecal samples collected from three populations of healthy adult volunteers (290
pig farmers, 316 abattoir workers, 160 (sub)urban residents) living in the south of The
Netherlands were analysed for the prevalence and degree of antibiotic resistance of
Ercterictoa eo/j. Significant differences in prevalence of resistance to amoxycillin,
neomycin, oxytetracycline, sulphamethoxazole and trimethoprim were observed. The pig
farmers showed the highest percentages of resistance and the (sub)urban residents the
lowest. In contrast no significant differences in high degrees of resistance were observed,
except for neomycin. Although both pig farmers and abattoir workers have regular
contact with pigs differences in prevalences of resistance were observed. However,
because abattoir workers with intensive and less intensive pig(carcass) contact did not
show significant differences, this is probably not the only important source of resistant
ErcfericWa co// in pig fanners.
The high antibiotic use by pig farmers (596) and abattoir workers (8%) than by
(sub)urban residents (0%) did not result in significantly different resistance percentages.
INTRODUCTION
Since their introduction antimicrobial agents have been successfully used for
treatment and prophylaxis of bacterial diseases in man and other species. The availability
of antibiotics means that many previously severe infections can now be treated. In
addition, antibiotics are used for growth promotion in animal husbandry and in agriculture
for crop protection. As antibiotics are not only very effective, but also remarkably safe
drugs this safety may have provoked liberal, even lavish, use in man and other animals.
The use of antibiotics, however, leads inevitably to emergence of resistance in the endo-
genous bacterial flora of treated persons and animals alike, against the antibiotics used or
to other drugs [4,18]. These enteric microorganisms may colonize other persons and ani-
mals and may spread resistance further by transfer of resistance plasmids to their faecal
flora. Consequently the environmental bacterial population may be contaminated after
faeces excretion. Lester « a/.[9] showed that persons with a few resistant bacteria in their
intestinal flora will have more chance of developing an infection with resistant bacteria
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after antibiotic therapy than persons with no resistant strains at all.
Many studies have examined the resistance of enteric bacteria in humans after
antibiotic therapy [1,6,8,17], but there is much less information available on the prevalen-
ce of antibiotic resistance in the faecal flora of healthy adults who have not used antibio-
tics recently [2,3,5,13,14]. However, such subjects are potential recipients of antimicro-
bial agents.
Farmworkers can directly become colonized by resistant bacteria due to close
contact with animals and their faeces [10,11,21], but are also directly exposed to antibio-
tics used for treatment or prevention of diseases in animals [12]. Abattoir workers have
daily contact with contaminated carcasses and gut contents [7,15,16,26]. A common risk
factor for colonization with resistant microorganisms in all three groups is personal use of
antibiotics.
To elucidate the importance of spread of resistance from food-animals to man we
studied in the same region the antibiotic resistance in three populations with different risks
of exposure to faecal bacteria from pigs i.e. pig farmers, abattoir workers and as a
control group, (sub)urban residents.
As the faecal flora is considered the most important reservoir of resistant microor-
ganisms and the antibiotic resistance of this flora is an indicator for the resistance of
potentially pathogenic bacteria in a population [8,9,13,28], faecal samples of these three
populations were analyzed for the prevalence and degree of antibiotic resistance of
Wa coW.
MATERIALS AND METHODS
Collection of the faecal samples.
Faecal samples, one from each person, were received from adult pig farmers
(290), pig-abattoir workers (316, of which 73 were meat inspectors) and (sub)urban resi-
dents (160) all living in the same area. After receipt, the samples were diluted (10') in
physiological saline, containing 20% (v/v) glycerol and stored at -20°C until examined.
All participants were asked to answer a questionnaire concerning antibiotic use in the
previous three months. Additional information about recent hospital stay and previous
antibiotic use by family members was obtained from the pig farmers and abattoir
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workers. The abattoir workers were also asked to give some information about keeping
domestic animals or pigs and their daily duties at the slaughterhouse.
Bacteriological analysis of the faecal samples.
The methods used to determine the prevalence and degree of resistance were as
described before [20]. In brief, after thawing the samples (10'), tenfold dilutions (10-M0"
*) in physiological saline were made. Thirty-seven /*1 of these dilutions were inoculated
with a spiral plater on Levine-agar plates (BBL 11221, [27]), a selective medium for
ErcfericWa co//, with and without antibiotics. The antibiotic concentrations (Table 1)
were based on NCCLS guidelines and modified where appropiate so that the data were
comparable with those of previous studies [2,3]. Only colonies with the appearance of
£rc/iericA/a co// (i.e. purple with a black center and a metallic green shine) were counted.
The total number and the number of resistant EjdiericWa co// were determined. The
minimum detection level of bacterial growth was 10" colony forming units (CFU) /g fae-
ces. From each agar plate without antibiotics one colony with the appearance of £rc/icric-
Ma co// was picked and tested for growth at 42°C overnight in tryptone water (Oxoid
L42) and for the indole reaction. If these tests were positive the microorganism was
considered to be £sc/iencA/a co//. For the first 50 isolates this identification was con-
firmed with Api-20E test (BioMerieux, Den Bosch, The Netherlands).
Prevalence of antibiotic resistance:
The prevalence of antibiotic resistance was defined as the percentage of faecal
samples showing any growth of Esc/ier/c/i/a co// on antibiotic-containing plates.
Degree of antibiotic resistance:
The degree of resistance of each sample was calculated as the percentage of the
total number of colonies that was resistant.
Two degrees of antibiotic resistance to a particular antimicrobial agent were distinguished
[3,13], namely the proportion of faecal samples with a ratio <50% was defined as low
degree of resistance, and the proportion of faecal samples with a ratio a 50% was defi-
ned as high degree of resistance (thus the majority of the strains showed resistance to
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that agent).
The antimicrobial agents used in this study were selected because these or closely
related compounds are regularly used for the treatment of humans and pigs in The
Netherlands, except apramycin which is only registered for use in animals but is not
extensively used in The Netherlands.
Statistical analysis.
In the analysis of the differences in prevalence and degree of antibiotic resistance
of the faecal samples of the three populations a Chi Square test with continuity correction
was performed. A Fisher Exact test was used if the expected frequency in at least one cell
was five or less. A two-sided significance level of <0.05 was used.
Multiple logistic regression was used to analyse the contribution of the origin of
the three study populations (independent variable) to the prevalence of resistance
(dependent variable) to a particular antibiotic. The antibiotics other than the dependent
variable were considered to be independent variables simultaneously, a two-sided
significance level of £0.05 was used.
The error of the method by using the spiral plater and by making tenfold dilutions,
calculated from the standard error of the mean, was 0.S log,,,.
RESULTS
Ninety-five percent of the pigfarmer colonies, 94% of the abattoir workers
colonies and 92% of the (sub)urban residents colonies that grew on Levine-agar showing
the morphology typical of &cAen'c/i/a co/i were identified as Esc/ieric/i/a co//. The other
colonies tested were also Enterobacteriaceae: K/e&y/W/a spp., GVrofcaaer spp., Emero&a-
CW spp. and Proteus spp. Finally, 278 samples of pig farmers, 289 of abattoir workers
and 150 of (sub)urban residents were included in the analysis. The other samples failed to
grow on the agar plates without antibiotics.
Antibiotic use was recorded by 15 pig farmers and 17 of their family members.
Two farmers had been hospitalized recently. Twenty-five abattoir workers and 25 family
members recorded antibiotic use, 5 abattoir workers had been hospitalized recently. By
the (sub)urban residents no antibiotic use in the three previous months was recorded.
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Intensive contact with pigs or pig carcasses was recorded by 182 abattoir workers, where-
as 104 workers had other duties as well or no direct contact. No information about
contact with pigs/carcasses was obtained from the remaining abattoir workers (n=30).
Fifty-two percent of the abattoir workers kept at least one domestic animal, whereas only
three persons kept pigs.
Prevalence of antibiotic resistance:
The prevalence and high degree of resistance are shown in Table 1 and Figure 1.
The most significant differences were noticed between pig farmers and (sub)urban
residents. The highest prevalence percentages were found for the pig farmers and the
lowest for the (sub)urban residents. The highest percentages (i.e. 47%) in the abattoir
workers and in the (sub)urban residents group were found for oxytetracycline and
amoxycillin, respectively, and in the pigfarmer group for sulphamethoxazole (84%).
Further analysis as to the patterns of prevalence of resistance to amoxycillin,
neomycin, oxytetracycline and trimethoprim of Eydieridi/a co/» isolated from the three
populations studied showed that the highest percentage of fully susceptible strains (34%)
as well as the lowest percentage of completely resistant isolates (4%) were found in the
(sub)urban residents. The converse was observed for the pig farmers.
Logistic regression analysis was performed to estimate the relative risk of
prognostic and risk factors (i.e. antibiotics used and population groups) with regard to the
(sub)urban residents. The odds ratio (OR), with the 95% confidence interval (CI), for
resistance to a particular antibiotic under consistent circumstances was calculated. Both
pig farmers (OR 0.4, CI 0.2-0.6) and abattoir workers (OR 0.5, CI 0.3-0.9) showed a
low odds ratio for amoxycillin resistance. The pig farmers showed a high odds ratio for
neomycin (OR 3.6, CI 2.5-5.4), sulphamethoxazole (OR 6.5, CI 4.0-10.6) and trimet-
hoprim (OR 2.1, CI 1.4-2.9). Resistance to oxytetracycline appeared to be independent of
the population tested. For the other antibiotics tested no significant prognostic and risk
factors were found.
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Table 1: Prevalence and high degree of antibiotic-resistant Escferic/u'a coW (%).
Antibiotic*
(mg/L)
AMX (25)
AP (32)'
CIP (4)
NA (32)
NE(8)
FT (50)
OT (25)
SMX (100)
TMP (8)
Prevalence
PF»
n=278
62
3
1
5
66
8
79
84
53
AW
n=289
42*
1
0
3
36'
4
47'
45"
23'
UR
n = 150
4 7 / "
nt<
0
1
25>~
3
36^1 ••
4 ( / "
i y
High degree
PF
n=275
7
0
0
1
7
0
10
17
4
AW
! n=289
9
0
0
0
2*
0
15
13
4
UR
n=150
13
nt
0
0
2 / ~
0
8
10
3
*AMX=amoxycillin, AP=apramycin, CIP=ciprofloxacin, NA=nalidixic acid,
NE=neomycin, FT=nitrofurantoin, OT=oxytetracycline, SMX=sulphamethoxazole,
TMP=trimethoprim
*PF=pig farmers, AW=abattoir workers, UR=(sub)urban residents
'Apramycin was only tested for the abattoir workers and the last 116 pig farmers faecal
samples.
"nt= not tested
Significantly different (P=s0.05): PF and AW: *, PF and UR: ' , AW and UR: ' ; PF and
AW and UR "
Degree of antibiotic resistance:
As presented in Figure 1 all three populations showed, except for neomycin,
similar percentages for high degree of resistance, but distinct variations in low degree of
resistance. The prevalence and degree of resistance of the meat inspector samples were
not significantly different from those of the abattoir workers. In addition, no differences
in prevalence and degree of resistance were observed between abattoir workers with and
without domestic animals. Because only three abattoir workers kept pigs no conclusions
about the influence of regular contact with pigs could be drawn.
3 2 • ''
No significant differences could be observed between abattoir workers with
intensive and those without or with less intensive contact with pig faecal contents or pig
carcasses.
No significantly different prevalence or degree of resistance rates were observed
for those people who had recently used antibiotics compared with those who had not used
antibiotics recently (pig farmers 5%, abattoir workers 8%). Nor were differences
observed for those recording recent hospital stay (pig farmers 1%, abattoir workers 2%)
or antibiotic use by family members (pig farmers 6%, abattoir workers 8%) when
compared with those who did not record these factors.
Figure 1. Prevalence of antibiotic resistance (%) of ErcAeric/i/a co/» from pig farmers
(PF, first bar per antibiotic), abattoir workers (AW, second bar) and (sub)urban residents
(UR, third bar). Also shown are the proportions (%) of low degree (<50%) and high
degree (S50%) of resistance. AMX=amoxycillin; AP=apramycin; CIP=ciprofloxacin;
NA=nalidixic acid; NE=neomycin; FT=nitrofurantoin; OT=oxytetracycline; SMX=sul-
phamethoxazole; TMP=trimethoprim.
%R
100
80
60
40
I high degree of R degree of R
AMX AP CIP NA NE FT OT SMX TMP
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DISCUSSION
The present study showed significant differences in prevalence of resistance
between pig farmers and (sub)urban residents for antibiotics extensively used in human
and veterinary medicine in The Netherlands [19]. In contrast the prevalence of a high
degree of resistance was, except for neomycin, not significantly different.
Several investigators have also observed differences in resistance of the faecal
flora of pig farmers/abattoir workers and urban residents [14,22,24] suggesting that
contact with live- stock was one route by which antibiotic resistance entered the human
gut flora. In contrast, Levy « a/. [13] found no significant difference between rural and
urban residents. The general trend in their study was for lower numbers of resistant
bacteria to be found in rural samples.
Remarkably, in the present study 15 (5%) pig farmers and 25 (89S) abattoir
workers used antibiotics during the three months previous to faecal sampling, whereas
none of the (sub)urban residents mentioned recent antibiotic use. This might be an
indication that people in contact with pigs or pig carcasses have a greater risk of bacterial
infections. A recent study about occupational risk factors for pig farmers showed that pig
farmers often suffer from chronic non-specific respiratory tract afflictions, due to regular
exposure in pig-stables to dust containing fungi, endotoxins, disinfectants etc. [23]. This
exposure results in a higher probability of respiratory tract infections, which could explain
the relatively high percentage of antibiotic usage among the pig farmers. Unfortunately,
no information about the reasons of antibiotic therapy was obtained. Moreover, in one of
the slaughterhouses studied, each month four percent of the workers were treated with
antibiotics for wounds or eczema (personal communication). Because the control group of
(sub)urban residents did not mention recent use of antibiotics, this therapeutic use among
pig farmers and abattoir workers might explain the higher prevalence of resistance in
these groups than in the (sub)urban residents. The relatively low numbers of pig farmers
(n = 15) and abattoir workers (n=25) who mentioned antibiotic use could not explain the
observed differences between the three populations. Also recent use of antibiotics by
family members appeared to be of no influence on antibiotic resistance in this study.
Contact with pigs/carcasses and pig faeces might be a possible reason for the diffe-
rences in prevalence of resistance observed between on one hand pig farmers and abattoir
workers and on the other hand the (sub)urban residents. Although no information about
3 4 _ . • '
the professions of the last group was obtained, it is to be expected that they do not have
regular direct contact with pigs. However, no significant differences were observed
between the abattoir workers with intensive and those with less intensive pig contact.
Therefore, other factors such as more intensive faecal contact, less personal hygiene and
protection taken by farmers as compared to abattoir workers might have contributed to
these differences. Moreover, it is very likely that direct contact with antibiotics used for
treatment of pigs is an additional risk factor for emergence of resistance and selection of
resistant strains in the intestinal flora of pig farmers. The results of the logistic regression
analysis underscore these suggestions.
Remarkably, significantly different prevalences and high degrees of resistance to
neomycin were observed for the pig farmers. Because neomycin is seldom used orally and
never parenterally in human medicine but frequently in pigs, the suggestion seems likely
that it is not human but mainly veterinary use of neomycin that is responsible for a higher
prevalence and high degree of resistance in pig farmers.
This study showed significant differences in the prevalence of antibiotic resistance
in the faecal flora of the three populations tested. Direct contact with pigs and pig car-
casses may contribute to antibiotic resistance in pig farmers and abattoir workers, in
addition to common risk factors such as personal use of antibiotics. Moreover, it is likely
that direct contact with antibiotics in medicated pig feed, i.e. mass medication, influences
the prevalence of antibiotic resistance in pig farmers. In the present study only prevalence
and degree of resistance were determined. Comparison of plasmids and transfer experi-
ments between pig and human isolates may elucidate the mechanisms involved.
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SUMMARY
From 25 March to 1 July 1991 faecal samples from healthy volunteers of two
cities and their rural surroundings, Weert (n=91) and Roermond (n=96) were collected
weekly and analysed for the presence of Enterobacteriaceae, resistant to ampicillin,
ciprofloxacin, nalidixic acid, neomycin, nitrofurantoin, oxytetracycline,
sulphamethoxazole or trimethoprim. In total, 682 and 690 samples from Weert and
Roermond, respectively were analysed for the prevalence and the degree of resistance to
each antimicrobial agent. The mean prevalence of resistance of the samples from Weert
varied from 28% ± 12% (mean ± S.D.) for ampicillin to 0.1% ± 1% (range 0% - 2%)
for ciprofloxacin. For Roermond the prevalence of resistance varied from 41% ± 7 % for
sulphamethoxazole to 0% for ciprofloxacin.
The high degree of resistance (i.e. >50% of the faecal flora of one particular
individual) varied from 8% ± 4% for sulphamethoxazole to 2% ± 2% for trimethoprim
for Weert. For Roermond the figures varied from 14% ± 4% for sulphamethoxazole to
0.3% ± 1 % (range 0% - 2%) for nalidixic acid. High degrees of resistance were not
found for ciprofloxacin and nitrofurantoin in either city.
In Weert ampicillin-resistant Enterobacteriaceae were isolated from 69/91
individuals.
INTRODUCTION
Emergence of antibiotic-resistant microorganisms continues to be an important
problem for the treatment of bacterial infections [3,14,15,20]. There is general agreement
that antibiotic use in general practice and in veterinary medicine is responsible in part for
the increase in the numbers of resistant bacteria. However, it is still not clear how the use
in humans (hospital and/or general practice) or that in animals has contributed to the
environmental pool of resistant microorganisms [1,8,17,25,27]. In hospitalized patients
relatively large amounts of antibiotics are used both for therapy and prophylaxis, resulting
in a high prevalence of antibiotic-resistant pathogens [21,23,24]. In veterinary medicine
antimicrobial agents are used in both these indications and as growth promoters at
subtherapeutic concentrations [2,10,16]. In addition, multiple-resistant bacteria are
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increasingly being isolated, and it is evident that these microorganisms can be spread
from animals to the human population as well as from person to person
[5,10,15,17,19,26]. Furthermore, resistant bacteria, e.g. Safrnone/fa spp. and
Cawipy/oiac/er ,/e/unf, can colonize the human intestinal tract after ingestion of
contaminated food [6,13,16].
The intestinal tract of the human open population is considered to be an important
reservoir of antibiotic-resistant bacteria [12], and several reports emphasize the
importance of the availability of information of the prevalence of antibiotic-resistant
isolates from faecal flora [7,18,22]. Relatively little is known about the numbers of
resistant bacteria in the healthy human population not receiving antimicrobials for therapy
or prophylaxis [7,18,22]. In addition, hardly any data are available on the reproducibility
of sampling, the intra-(or within) individual variation regarding the presence of antibiotic
resistance in faecal isolates and possible changes in resistance over time.
In this study, the prevalence and the degree of resistance for each antimicrobial
agent were calculated for all faecal samples each week and for the entire 15-week period
for each individual in the study.
MATERIALS AND METHODS
Sample collection
From 25 March to 1 July 1991 faecal samples were collected once weekly for a
period of 15 weeks in two medium sized cities, Weert and Roermond, (4hlO* and 43»10*
inhabitants, respectively) 30 km apart in the south of the Netherlands. Volunteers were
randomly selected at the registry office. Of the first 100 people in Weert and Roermond
who consented to participate in the study, 91 and 96 subjects finally entered the study. Of
these individuals 61/91 (67%) and 63/96 (66%), respectively, could be followed up for at
least ten weeks. Only one individual reported having taken antibiotics (tetracycline) in the
previous 15 weeks.
Sample processing
•, . One gram of fresh faeces was suspended in 9 mL of 0.9%(w/v) NaQ,
supplemented with 20%(w/v) glycerol and stored at -20°C until assayed. After thawing
this suspension, serial ten-fold dilutions were made up to a final dilution of 1:10* and
0.037 mL of these dilutions were inoculated on to Levine agar plates (Oxoid CM69) with
and without antibiotics using a spiral plater (Lameris Laboratorium B.V., Breukelen, the
Netherlands). On Levine agar plates &cferic/i/a co// has a purple appearance with a black
centre and a green metallic sheen. Sometimes the green metallic sheen disappears if
antibiotics are added to the Levine agar. Other bacteria that grow on these agar plates
are: Ttawfomo/ios spp, 7(/eZ>s/e//a spp, E/tferotacrer spp, Ci/rotcaer spp and Pro/e«i spp.
The following antibiotic concentrations were used based on NCCLS guidelines and
modified where appropriate so that the data were comparable with that of previous studies
[7]: ampicillin 25 mg/L, ciprofloxacin 4 mg/L, nalidixic acid 32 mg/L, neomycin 8
mg/L, nitrofurantoin 50 mg/L, oxytetracycline 25 mg/L, sulphamethoxazole 100 mg/L
and trimethoprim 8 mg/L. If trimethoprim was used 5%(v/v) lysed horse-blood was added
to the agar. After incubation at 37°C for 18-24 hours the total number and the number of
resistant Enterobacteriaceae were determined. The lowest number of Enterobacteriaceae
detectable was 10" cfu/g faeces, the highest concentration approximately 10' cfu/g faeces.
One colony with the colonial morphology of E$cAe/7c/»a co/i was randomly picked out
from each agar plate ± antibiotics and tested for indole reaction and growth at 42°C.
Isolates yielding positive results for both tests were considered to be Esc/ierictoa co// and
stored at -70°C in small plastic tubes containing beads (Microbank, PRO-LAB
Diagnostics, the Netherlands).
The prevalence of antibiotic-resistance was defined as the number of faecal
samples with resistant Enterobacteriaceae divided by the total number of samples tested
multiplied by 100%. The degree of resistance of each sample was defined as the ratio (in
%) between the number of colonies grown on the agar plates ± antibiotics. If the ratio
was &50 % or <50% the degree of resistance was defined as high or low. The
prevalence and the degree of resistance were calculated over time for all the samples
tested (n=682 and n=690) for Weert and Roermond, respectively, and for each
individual participant (n=91 and n=96 for Weert and Roermond, respectively).
For each week, the prevalence and the degree of resistance to each antibiotic were
calculated on the basis of all the samples with a positive growth on the agar plate without
antibiotics. The mean values for the entire 15 week period were also calculated. In
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addition, for each individual the mean values for the entire IS week period were
calculated.
Statistics
The error in the method by making serial ten-fold dilutions and by using a spiral
plater was 0.5 '"log (i.e. ± 5x10"). If the number of colonies found on the agar plates
without antibiotics from the faecal samples of one particular individual was not
significantly different from the mean value, the corresponding number of colonies on the
agar plates with antibiotics was included in the analysis of prevalence and degree of
resistance.
The F-test, Students f-test and chi-square test were used to analyse statistical
differences (P<0.05, two-tailed) between the results for the cities of Weert and
Roermond. Students f-test was also used to predict the number of individuals with a high
degree of resistance to any of the antibiotics used.
The intra-(or within) individual variation was determined by analysis of variance.
Variation of the prevalence and the degree of resistance within one person was due to
measurement error as well as biological variation.
RESULTS
Prevalence of antibiotic resistant Enterobacteriaceae in faecal samples
The total number of faecal samples analysed was 943 and 956 for Weert and
Roermond, respectively. After incubation at 37°C for 18-24 hours no growth was visible
on the agar plates without antibiotics in 249 and 255 samples from Weert and Roermond,
respectively. Only those samples with a colony count on the agar plates without
antibiotics, 682 and 690 samples for Weert and Roermond, respectively, were analysed.
All further calculations were based upon those samples.
The mean total number, i.e. 'iog(CFU), of Enterobacteriaceae in the samples
tested was for Weert 6.02±1.25 per gram faeces with a range between 3.43 and 8.43.
For Roermond 6.30±1.00 was found, with a range between 3.43 and 8.43.
Of the randomly picked colonies 93% (3007/3226) were considered to be
ricAui cofi. No resistant Enterobacteriaceae were isolated from 10/91 and 9/96
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individuals, for Weert and Roermond, respectively.
The mean prevalence of antibiotic-resistant Enterobacteriaceae varied in the
samples from Weert (n=682) from 28% for ampicillin and sulphamethoxazole to 0.1%
for ciprofloxacin (Figure 1, only one colony of X7eW/a spp. was found on the agar
plate containing ciprofloxacin). For the samples from Roermond (n=690) the percentages
varied from 41% for sulphamethoxazole to 0% for ciprofloxacin (Figure 1). The mean
prevalence of resistance to oxytetracycline and sulphamethoxazole in Roermond was
significantly higher than in Weert (P<0.05, two-tailed).
Figure 1. Frequency of low degree of resistance for Weert ( | ,n=682) and Roermond
( Q ,n=690) and frequency of high degree of resistance for Weert ( 0 ,n=682) and
Roermond (^3,n=690).
Amp=ampicillin; cip=ciprofloxacin; nal = nalidixic acid; neo = neomycin;
nit=nitrofurantoin; oxy=oxytetracycline; sul=sulphamethoxazole; tmp=trimethoprim.
amp cip nal neo nit oxy sul tmp
Antimicrobial agent
43
The mean percentages of the faecal samples with a relatively low degree of
resistant Enterobacteriaceae varied in Weert from 22% for oxytetracycline to 0.1% for
ciprofloxacin; in Roermond from 27% for sulphamethoxazole to 0% for ciprofloxacin
(Figure 1). The mean percentages of a high degree of resistance varied in Weert from 8%
for sulphamethoxazole to 0% for ciprofloxacin, nalidixic acid and nitrofurantoin, in
Roermond from 14% for sulphamethoxazole to 0% for ciprofloxacin and nitrofurantoin
(Figure 1).
Significant differences in the degree of resistance between Weert and Roermond
were observed for trimethoprim (i.e. high degree) and for sulphamethoxazole (i.e. high as
well as low degree) (P<0.05, two-tailed).
During the 15-week period the individual variation in the number of
Enterobacteriaceae present in the faecal samples was ± 1.25 '"log and ± 1.36 '"log for
Weert and Roermond, respectively. Testing 15 samples from one subject consecutively,
the total variation in the results observed is considered to be due to the measurement error
variation (S.D.) and the biological variation (S.D. individual). Although variations in the
prevalence and the degree of resistance did occur, in those samples with a high number of
Enterobacteriaceae/g faeces the high degree of resistance over time was more or less
constant (Figure 2).
Figure 2. The '"log (CFU) of bacteria within one person during a period of 15 weeks.
-*- Blank; -f- ampicillin; •*• oxytetracycline; -o sulphamethoxazole.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
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Ampicillin resistance was found in 69/91 individuals from Weert, resistance to
sulphamethoxazole was observed in 69/96 individuals from Roermond (Figure 3). The
prevalence of resistance for sulphamethoxazole in Roermond was significantly higher than
in Weert (P<0.05, two-tailed). The number of individuals with a relatively low
proportion of resistant Enterobacteriaceae in the faecal samples, varied in Weert from 66
for ampicillin to one for ciprofloxacin (Figure 3). For Roermond the numbers varied from
69 for sulphamethoxazole to none for ciprofloxacin (Figure 3). A high degree of
resistance to ampicillin was observed in three and seven individuals from Weert and
Roermond, respectively. To ciprofloxacin, nalidixic acid and nitrofurantoin no high
degrees of resistance were found for either population (Figure 3).
In Roermond the low degree of resistance to sulphamethoxazole was significantly
different to that in Weert (P<0.05, two-tailed). The percentages of a high degree of
resistance to either ampicillin, oxytetracycline, sulphamethoxazole or trimethoprim in the
populations studied, can be predicted to be 29% and 35% for Weert and Roermond,
respectively (P<0.05, two-tailed).
Figure 3. Frequency of low degree of resistance in faecal samples for Weert
( I .number of individuals=91) and Roermond ( • ,n=96); and frequency of high
degree for Weert ( 0 , n = 9 1 ) and Roermond ( 0 ,n=96). For legend see Figure 1.
80
70
60
50
40
30
20
10
Fs
s
1
....... In,
a
R
amp cip oxy sul tmp
Antimicrobial agent
47
DISCUSSION
This study shows a relatively high prevalence of resistance of Enterobacteriaceae
to ampicillin, oxytetracycline and sulphamethoxazole in healthy individuals from two
relatively small cities in the south of the Netherlands. The prevalence of antibiotic resis-
tance was more or less constant during the 15-week study period.
It was quite remarkable that 28% of the samples, both for Roermond and Weert,
yielded no growth of Enterobacteriaceae on the agar plates without antibiotics. It is not
very likely that this finding was due to the method used: as soon as the samples were
delivered to the laboratory a 1:10 dilution was made in glycerol (20%(w/v)) and kept at
-20°C until analysis, which was performed with a spiral plater. The lowest detection limit
using this apparatus was 10* CFU/g faeces, thus no growth means that the sample
contained less than 10* CFU/g faeces. Moreover, no growth inhibitory factors could be
demonstrated in the 50 randomly selected faecal samples yielding no growth. It is also
unlikely that freezing the 1:10 dilution of specimens affected growth as for positive
samples no appreciable difference between fresh and frozen samples was found. Although
it is still not clear why 28% of the samples analysed contained less than 10* CFU/g faeces
it can be assumed that samples yielding no growth are a random part of the total number
of samples collected. All data were calculated on the basis of those samples that yielded
Enterobacteriaceae, thereby precluding any implications that samples yielding no growth
could have on the results.
A wide range of prevalence percentages have been described in different studies,
especially for ampicillin (25%-99%) and sulphamethoxazole (45%-86%; Table). There
are several reasons for the variation in the prevalence of resistance observed. Differences
in selective concentration of antibiotic used and in the populations studied are most
important. In the studies of Bonten [7] and this one the spiral plater was utilized for
quantitative determination of the number of CFU/g faeces. Most other studies used a
semi-quantitative method. It is to be expected that the prevalence of antibiotic resistance
is influenced by the method used more than the degree of resistance. There is less
variation between the high degree of resistance. For ampicillin the data presented in the
different studies varied from 5% to 17%, for oxytetracycline from 6% to 19% and for
sulphamethoxazole from 8% ± 4% to 37%. For both sulphamethoxazole and
oxytetracycline the prevalence of resistance of Enterobacteriaceae in the present study is
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much lower than that found by Bonten « a/., 1990 [7] and Degener er a/., 1990 [9].
The tendency to a decrease in prevalence and in a high degree of resistance to
sulphamethoxazole may be due to the decrease in the use of this agent since 1980. Very
little sulphamethoxazole was prescribed by the general practitioners in Weert and
Roermond in 1991 (personal communication). Trimethoprim was prescribed twice as
frequently in Weert compared to Roermond, and sulphamethoxazole-trimethoprim ten
times more frequently. However, in Roermond norfloxacin was prescribed eight times as
often compared to Weert. It is very likely that the general practitioners in Roermond
prescribed norfloxacin instead of trimethoprim due to the high degree of resistance to
sulphamethoxazole and trimethoprim. For tetracycline the explanation for the percentages
found is less self-evident. The population tested in this study lives in an area with many
stock-farms, while the populations tested by other authors were mainly city-dwellers. In
veterinary medicine large amounts of tetracycline are used for therapy and prophylaxis as
well as for growth promotion, therefore a higher prevalence may be expected in this study
compared to others (Table). However, our values are of the same order of magnitude as
those found by Levy « a/., 1988 [18] and Degener « a/., 1990 [9].
In this study no ciprofloxacin-resistant EscAericWa co/i were found. At present
most Enterobacteriaceae are highly susceptible to the fluoroquinolones although the use of
enrofloxacin in poultry has caused resistance in Ca/npy/ofcac/er spp. (Endtz « a/., 1991
[11]. Large-scale use of quinolones in veterinary medicine may further increase the
prevalence of resistance (Endtz ef a/., 1991 [11].
At present no data are available on the prevalence of resistance in the same
individual over time. Bonten er a/., 1990 [7] and Amyes « a/., 1992 [3] tested only one
sample per individual. Degener er a/., 1990 [9] tested the same population (but not the
same individuals) twice with a 5 year interval. However, the study does not present
census and population dynamic information on individuals of the original study
population. Levy er a/., 1988 [18] compared the prevalence of antibiotic resistance in the
aerobic Gram-negative gut flora cultured from faecal samples from medical students with
the resistance in hospitalized and ambulatory patients ten years earlier.
To our knowledge this is the first study in which faecal samples of the same
individuals were tested weekly over a period of 15 weeks. The data clearly showed that a
49
high degree of resistance in the individuals remained more or less constant over time
(Figure 2). For the low degree of resistance more variation was observed (data not
shown). Consequently testing only once is, as expected, less accurate. The most important
cause of the variations observed in the prevalence and the degree of resistance was
biological variation, rather than measurement error variation. In other studies, based upon
one sample per individual, one does not take into account the biological variation. In
those studies the variation in the data mentioned is also at least ±1 .25 '"log.
Testing over a period of time gives the possibility to predict the prevalence of
resistance in the near future. This calculated future prevalence for ampicillin,
oxytetracycline, sulphamethoxazole and trimethoprim in the population studied is 26%
and 29% for Weert and Roermond, respectively. Whether these values correspond with
the actual prevalence warrants surveillance of resistance of the faecal flora of healthy
individuals. This surveillance of resistance will provide general practitioners with essential
data for their choice of empirical therapy [22]. The Infectious Disease Society of America
stressed the importance that hospital formularies are based on antibiotic susceptibility
patterns of the own hospital isolates. General practitioners also have to base their
empirical therapy on susceptibility data of outpatient isolates. Taking into account that the
bowel flora are considered to be an important reservoir for antibiotic resistance genes
[12], especially outside hospitals, knowledge about the antibiotic resistance of these
isolates from healthy individuals will contribute to an educated guess of the empirical
therapy.
SO
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Table. Comparison of data from different studies.
Ampicillin :
(mg/L)
prevalence (%)
high degree (%)
Oxytetracycline :
(1)
1978-80
40
25
5
(2)
1987
40
27
11
(3)
1988
30
35
17
(4)
1990
25
76
8
(5)
1992
10
99
-
(6)'
1992
W
25
28±12
7±5
R>
25
33±12
9±5
(1) (2) (3) (4) (5) (6)'
1978-80 1987 1988 1990 1992 1992
(mg/L)
prevalence (%)
high degree (%)
Sulphamethoxazole :
(mg/L)
prevalence (%)
high degree (%)
30
42
12
(1)
1978-80
100
45
19
30
20
6
(2)
1987
100
46
21
10
30
19
(3)
1988
-
-
-
25
47
11
(4)
1990
100
86
37
W
25
25 ±7
3±3
(5) (6)'
1992 1992
W
100
28±10
8±4
R
25
31±7
5±4
R
100
41±7
14±4
' (1) Degener « a/ '78-'8O; (2) Degener « a/ '87; (3) Levy « 0/ '88; (4) Bonten « a/
'90; (5) Amyes « a/ '92; (6) present study.
*W=Weert and R=Roermond.
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CHAPTER IV
CARRIAGE OF ANTIBIOTIC-RESISTANT ESCHErt/CHM COL/
BY HEALTHY VOLUNTEERS DURING A 15-WEEK PERIOD.
N. London, R. Nijsten, A. van den Bogaard, E. Stobberingh
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SUMMARY
Erc/ierictoa co/; strains (n=678 and n=670) isolated from faecal samples from 90
and 93 healthy volunteers of two cities, Weert and Roermond respectively, were analysed
for their susceptibility to 12 antimicrobial agents, during a lS-week period. Significant
differences between both cities in the distribution of the MIC values were observed for
apramycin, chloramphenicol, kanamycin, neomycin, nitrofurantoin, sulphamethoxazole
and trimethoprim. For Weert (n=678) the antibiotic resistance percentages varied from
0.4% for nalidixic acid to 26.7% for sulphamethoxazole. For Roermond (n=670) the
figures varied from 0.6% for nitrofurantoin to 37.5% for sulphamethoxazole. Resistance
to amoxycillin/clavulanate was not found in either city.
The most frequent pattern was resistance to sulphamethoxazole only, followed by
resistance to oxytetracycline, streptomycin and sulphamethoxazole.
In each individual there was only a small variation in resistance patterns of the
isolates, i.e. the majority had one (n=51) or two (n=63) patterns with a maximum of
five during the lS-week period. A fully susceptible pattern was found in the strains from
38 individuals.
INTRODUCTION
Bacterial resistance to antimicrobial agents is a problem of worldwide concern
[18,23,27]. Also to recently introduced antibiotics, such as the newer fluoroquinolones
[14,35] and the third generation cephalosporins [11,16,28] bacterial resistance does occur.
In contrast to the extensive data available on antibiotic susceptibilities of hospital isolates
[6,7,9,24,25,30] less information is available on the incidence of antibiotic-resistant
strains in general practice [2,10,34] or in healthy volunteers [1,21]. Knowledge on the
antibiotic resistance of strains colonising healthy people is important for several reasons.
First, antibiotic-resistant strains are considered to be the largest reservoir of resistance
genes [13]. Second, the mechanism of resistance in these isolates may be different from
that in hospital strains and subsequently the therapy for them may be different as well [8].
Finally the correlation between antibiotic resistance of colonising strains and the resistan-
ce of infecting microorganisms as clearly demonstrated by Lester « a/. [19] stressed the
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importance of ongoing antibiotic surveillance of colonising strains in healthy individuals
to predict resistance in future infecting isolates and to support the antibiotic choices of
empiric therapy.
Therefore a 15-week surveillance period was started during which faecal samples
from about 100 healthy volunteers in each of two cities in the same region were collected
weekly. One of the aims was to determine the antibiotic resistance patterns of the faecal
Escftcric/u'a co// from all samples and to analyse the variation in antibiotic resistance of
the isolates from each individual over the 15-week period. Also the mechanism of
resistance to one of the antibiotics, trimethoprim, was tested.
MATERIALS AND METHODS
Sample population
Faecal samples of healthy volunteers of two cities and their rural surroundings,
Weert (n=91) and Roermond (n=96), were collected weekly from 25 March to 1 July
1991 as described previously [22].
Sample processing
Faecal dilutions (1:10 to 1:10*) were applied onto Levine agar plates (Oxoid
CM69, Ltd., Basingstoke, England) without antibiotics using a spiral plater (Lameris
Laboratorium B.V., Breukelen, the Netherlands). Colonies with the colonial morphology
of £sc/i«ric/i/a co// were randomly picked out from each agar plate without antibiotics,
one colony per faecal sample, and tested for indole reaction and growth at 42°C. Only
isolates yielding positive results for both tests were considered to be Esc/ieric/i/a co//. The
identification of 50 randomly chosen ErdiericA/a co// strains, identified as mentioned
above, were confirmed using the API 20E system to be £rc/icric/ua co//.
Susceptibility tests
The antibiotic susceptibility was determined using a microbroth dilution method in
Iso-Sensitest Broth (Oxoid CM473). An inoculum of 5x10* CFU/ml was used. The plates
were incubated for 18-24 hours at 37°C, the MIC being defined as the lowest antibiotic
concentration completely to inhibit growth. £jcAenc/»a co// ATCC 25922 and
Owp/er TV
coW ATCC 35218 were used as reference strains. The antimicrobial agents used are
shown in Table 1. The breakpoints for resistance were those recommended by the guideli-
nes of the Dutch Working Party on Antimicrobial Susceptibility Testing [17]. For
apramycin the breakpoint of resistance was > 16 mg/L [15].
Characterisation of trimethoprim resistant strains
Plasmid DNA was isolated as described by Sambrook « a/. [29] Two probes enco-
ding trimethoprim resistance were used : one was a 0.49 kb /^ unZ/BaffiW/ fragment of
pLKO627 encoding the <//j/W gene and the other was a 0.49 kb f//>a/ fragment of pLKO2-
2A encoding the <#//rV gene [32,33]. The DNA probes were purified by extraction with
diatoms earth from agarose gels and labeled with digoxigenin according to the manufac-
turer's instructions (Boehringer Mannheim Biochemica, Mannheim, Germany). The
strains were screened by making colony blots on nylon membranes (Nytran) according to
the manufacturer's instructions (Nytran, Schleicher & Schuell, Den Bosch, the Nether-
lands). As positive controls the strains containing the plasmids pLK0627 and pLKO22A
were used, as negative control Esc/iericWa co//' K-12. The probes for type I and V
hybridised only with their own positive control strains; no other cross-hybridizations were
detected. Prehybridization and hybridization were performed under stringent conditions (
50%(v/v) formamide and 5xSSC [lxSSC is 0.15 M NaCl plus 0.015 M sodium citrate] at
42°C, and washes in 2xSSC plus 0.1%(w/v) SDS and O.lxSSC plus O.196(w/v) SDS at
68°C. The detection of digoxigenin-labelled nucleic acids was performed by chemolumi-
nescence on radiographic films (Kodak X Omat AR).
Statistics
The F-test, chi-square test, Mann-Whitney test and hierarchical cluster analysis by
average linkage (UPGMA) and Squared Euclidian distances (i.e. Distance (X,Y)=E(Xj-
Yj)*) were used to analyse whether there were significant differences (P<0.05, two-
tailed) between the cities Weert and Roermond.
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RESULTS
Antibiotic resistance
In faecal samples from one individual from Weert and three individuals from
Roermond, EjcAencWa co// was not detected. Finally, a total of 678 and 670 &c/i«ricWa
co/i strains for Weert and Roermond respectively were analysed for their susceptibility to
12 antimicrobial agents. Significant differences in the distribution of the MIC values were
observed for apramycin, chloramphenicol, kanamycin, neomycin, nitrofurantoin,
sulphamethoxazole and trimethoprim (P<0.05) (Table 1).
For further analysis all values were first classified by hierarchical cluster analysis.
Consequently, slight differences between the frequencies found in Table 1 and Table 2
might occur. The frequency of resistance to the antimicrobial agents tested is shown in
Table 2. The highest frequency of resistance was found for sulphamethoxazole, 26.7%
and 37.5%, followed by streptomycin (20.5% and 26.9%) and oxytetracycline (17.3%
and 24.6%). Resistance to amoxycillin/clavulanate (2:1) was not observed in the samples
of either city. High MIC values, i.e. MIC & 512 mg/L, for apramycin were observed for
three isolates of Roermond, which were isolated from one individual. All three were also
resistant to gentamicin (MIC & 8 mg/L). High level resistance to nalidixic acid (MIC a
128 mg/L) was observed for three and ten isolates from Weert and Roermond respective-
ly, isolated from three and six individuals. None of these strains were resistant to
ciprofloxacin (MIC ^ 1 mg/L).
Oiap/er /V
Table 1. Distribution of MIC values for isolates from Weert (n=678) and Roermond (n=670).
Agent*
AM
AP
AM/CL
CH
KA
NA
NE
NI
OX
ST
SU
TR
City
W*
R»
W
R
W
R
W
R
W
R
W
R
W
R
W
R
W
R
W
R
W
R
W
R
Number of strains i
0.06 0.13 0.25 0.5
0
1
0
0
0
0
2 58 247 285
18 112 238 20C
nhibited
1
1
4
0
1
1
3
0
1
7
3
327
374
4
6
0
1
i 34
) 32
2
22
5
31
36
14
8
9
6
212
253
109
137
282
216
5
1
8
10
36
29
1
6
by concentration
4
365
404
345
382
296
294
101
170
385
338
501
477
36
49
27
50
142
176
365
342
0
1
1
4
8
210
158
244
201
283
269
485
404
42
44
58
42
13
8
390
438
392
310
122
94
248
209
0
0
16
23
13
46
41
84
96
49
27
15
10
0
1
2
4
221
151
19
9
17
21
162
110
21
6
(/ig/ml)
32
1
1
11
6
0
0
1
2
1
2
0
0
8
1
25
19
1
2
21
48
41
49
0
0
64
1
0
1
0
0
0
3
1
8
6
0
2
5
12
4
4
1
2
35
41
28
28
1
0
128
3
0
0
0
0
0
30*
59
3
1
3
8
5*
6
2"
1
3
10
82
94
19
17
1
0
256
0
3
0
0
0
0
12'
16
112
151
25
6
0
1
512 1024
52
81
0'
3
0
0
37 118*
18 232
27 0-
51 2
' AM=amoxycillin; AP=apramycin; CH=chloramphenicol; CL=clavulanate; KA=kanamycin;
NA=nalidixic acid; NE=neomycin; NI=nitrofurantoin; OX=oxytetracycline; ST=streptomy-
cin; SU=sulphamethoxazole; TR=trimethoprim.
'W=Weert and R=Roermond 'P<0.05
61
57
15
0
59
24
3
18
5
117
139
181
51
(8.4)
(2.2)
(8.7)
(3.5)
(0.4)
(2.7)
(0.7)
(17.3)
(20.5)
(26.7)
(7.5)
83
8
0
68
26
10
19
4
165
180
251
65
(12.4)
(1.2)
(10.1)
(3.9)
(1.5)
(2.8)
(0.6)
(24.6)
(26.9)
(37.5)
(9.7)
Table 2. Antibiotic resistance of isolated £jc/ieric/ji'fl co# from Weert (n=678) and
Roermond (n=670) to 12 antimicrobial agents.
Antimicrobial agent" Number (percentage) of resistant isolates for
Weert Roermond
AM
AP
AM/CL
CH
KA
NA
NE
NI
OX
ST
SU
TR
" For abbreviations, see Table 1
' P<0.05, two-tailed
Antibiotic resistance patterns of Escftpn'c/i/'o co//
Multiple resistance, i.e. resistance to two or more antibiotics, was found in
202/670 strains from Roermond and 150/678 from Weert (P<0.05, two-tailed).
The resistance pattern most frequently observed for Weert and Roermond was
resistance to sulphamethoxazole only, n=80 and n=89, respectively (Table 3). With a
distinctly lower frequency resistance to oxytetracycline, streptomycin and sulphamet-
hoxazole was observed in both groups (n=22 and n=25), followed by streptomycin alone
in Weert (n=20) and oxytetracycline and streptomycin in Roermond (n=25). Sus-
ceptibility to all agents tested was found for 395 (58.3%) and 330 (49.3%) isolates from
Weert and Roermond, respectively (Table 3).
The majority (i.e. 568/678 and 551/670) of the faecal isolates of both cities had a
resistance pattern belonging to one of the patterns shown in Table 3. In addition 23 pat-
terns, i.e. only 42/678 strains were unique for Weert and 35 patterns, only 66/670 strains
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for Roermond, giving rise to 51 and 63 different patterns for Weert and Roermond,
respectively. Testing faecal samples from each individual consecutively during a 15-week
period, individual variation in resistance patterns could be analysed. One to seven
different patterns in each individual were observed.
Table 3. The ten most frequent patterns of resistance for Escteridi/a co// isolates from
Weert (n=678) and Roermond (n=670).
Weert
Pattern' (n)
Roermond
Pattern (n)
--> 395
SU 80
OX-ST-SU 22
ST 20
OX 14
AM-CH-OX-ST-SU-TR 13
CH-OX-ST 9
AM-OX-ST-SU 8
AM 7
AM-OX-ST-SU-TR 6
CH-OX-ST-SU-TR 6
568/678
—
SU
OX-ST-SU
OX-ST
ST
ox-su
AM-OX-ST-SU-TR
OX
ST-SU
AM-CH-OX-ST-SU-TR
CH-OX-SU-TR
330
89
25
25
16
15
13
10
10
9
9
551/670
' For abbreviations, see Table 1
63
27
27
17
14
4
0
1
24
36
20
4
6
3
0
The majority of the isolates had one (n=51) or two (n=63) different resistance patterns
(Table 4).
Table 4. The number of resistance patterns present in each individual from Weert (n=90)
and Roermond (n=93).
Number of patterns Number of individuals
Weert Roermond
1
2
3
4
5
6
7
Because there were no significant differences in the number of patterns in the
individuals of both cities, for further analysis all individuals were grouped together.
The number of patterns in relation to the number of strains tested per individual is
given in Table 5. Because one strain from each sample was picked out, the number of
strains corresponded to the number of samples tested. The number of samples (i.e.
strains) analysed per individual ranged from one to 13, whereas the number of different
patterns observed in most individuals during the study period was not more than five.
Only four individuals showed during 8,10 and 11 weeks, six and seven different patterns.
A fully susceptible pattern during the 15-week period was found in 38/51 individuals.
Thus the isolates from these individuals had only one pattern (i.e. susceptible to all
agents) during the whole period.
Trimethoprim resistance
Resistance to trimethoprim was observed in 116 isolates, from which 81 were
resistant to high levels of trimethoprim (MIC & 512 mg/L). These strains were isolated
from 29 individuals. After screening for the presence of the most frequently occuring
dihydrofolate reductase genes, i.e. <#i//7 and <//i/rV , all individuals except one were posi-
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tive for <tt/W, while 9/29 individuals were positive
Table 5. The number of patterns in relation to the number of strains tested per individual.
Number of samples Number of individuals Number of patterns
1 2 3 4 5 6 7
1
2
3
4
5
6
7
8
9
10
11
12
13
10
11
14
9
14
11
12
22
26
17
16
11
10
10
4
7
2
3
5
4
3
6
2
2
1
2
7
5
3
5
3
4
11
9
7
5
2
2
2
3
3
2
1
4
6
4
3
5
4
1
3
2
3
3
2
1
2
1
1
1
1
2
1 1
3 1 1
1
1
51 63 37 18 10 3 1
DISCUSSION
The main feature of the study was the high frequency of resistance to sulphamet-
hoxazole, streptomycin and oxytetracycline of the Esc/ieric/ua co// strains (n=678 and
n=670) isolated from faecal samples of 90 and 93 healthy volunteers from Weert and
Roermond, respectively. Moreover the differences in resistance to these compounds as
well as to amoxycillin were significant (P<0.05). In addition, our data during the 15-
week period strongly suggest that the pool of antibiotic-resistant strains is relatively
constant over time and is maintained in the faecal flora of healthy individuals who have
not taken any antibiotics recently.
The ten most frequent resistance patterns in this and in other studies are shown in
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Table 6. Although some differences did occur the majority of the resistance patterns
observed in the studies mentioned were quite similar despite the different populations
studied. The population analysed by Linton « a/. [21] and in this study consisted of
healthy people; Miller er a/. [25] studied in- and outpatients and Levy er a/. [20]
analysed healthy people, laboratory workers and hospital patients. In the present study,
resistance to chloramphenicol was always (except for two strains) correlated with
resistance to other antimicrobial agents. The most frequent pattern was resistance to chlo-
ramphenicol, oxytetracycline, streptomycin and sulphamethoxazole. Often resistance to
amoxycillin and trimethoprim was present as well. Chloramphenicol and tetracycline do
select for the chromosomal Mar-system which confers also resistance to structurally
unrelated agents, including nalidixic acid, fluoroquinolones, rifampin, penicillins and
cephalosporins. Isolates being resistant to oxytetracycline, chloramphenicol and nalidixic
acid are more likely to select for this Mar-system and could therefore be a direct potential
clinical problem in the hospital environment [5,12].
Resistance to apramycin, an aminoglycoside used only in veterinary medicine, was
observed in 23 EscAericA/a co// strains, three of which were resistant to high levels of
apramycin (MIC & 512 mg/L). This high level apramycin-resistance confers also
resistance to gentamicin, which is probably due to production of plasmid-mediated
aminoglycoside acetyltransferase 3-IV (AAC(3)-IV). Notably, of the 187 individuals
tested who did not have a history of recent hospital stay or antibiotic use, in one
individual this type of resistance was present. It is to be expected that in the hospital
environment a higher prevalence and spread of this plasmid will occur [3,4].
The presence of both aVj/W and tf7?/rV in one strain was also observed by Singh ef
a/. [31]; of all colony isolates 21% hybridised under stringent conditions, and all of these
were with type I (17%) or type V (4%); of the type V positive ones, two were also
positive for type I. Resistance to trimethoprim was often correlated with resistance to
amoxycillin, oxytetracycline, streptomycin, sulphamethoxazole and chloramphenicol.
In the present study, in the majority of the individuals only one or two different
resistance patterns, with a maximum of five, could be observed, which were independent
of the number of strains tested for that individual. In contrast, Levy « a/. [20] found that
90% of all individuals showed a gain (47.6%) and/or a loss (65.7%) of one or more
detectable resistances when analysing two samples obtained from individuals of the
/V
ambulatory group off antibiotics. No distinct explanation could be given for the differ-
ences in antibiotic resistance between the two populations studied. Because both cities
have the same socio-economic level, and are only 30 km apart, it is not very likely that
environmental circumstances could explain the differences observed. Only one person
reported having taken antibiotics, i.e. tetracycline, during the study period so the
influence of individual recent antibiotic use on the resistance percentage observed was
negligible. Moreover differences in antibiotic prescriptions by the general practitioners
during the year preceding the start of the surveillance could not explain the differences in
resistance observed. Sulphamethoxazole is hardly used in either city. Amoxycillin has
been prescribed slightly more in Weert compared to Roermond, whereas for the antibiotic
resistance the reverse was found (8.4% and 12.4%), Quinolones (ciprofloxacin and
norfloxacin) were eight times more frequently used in Roermond. In contrast, trimethop-
rim alone and in combination with sulphamethoxazole was used twice and eight times as
much in Weert compared to Roermond. However the differences in antibiotic prescripti-
ons were not reflected in the antibiotic resistance. Further studies to analyse factors
influencing antibiotic resistance in healthy individuals remain to be performed.
Table 6. Comparison of the ten most frequent patterns of resistance for four different
studies.
Weerf
su'
OX-ST-SU
ST
OX
AM-CH-OX-ST-SU-TR
CH-OX-ST
AM-OX-ST-SU
AM
AM-OX-ST-SU-TR
CH-OX-ST-SU-TR
Roermond*
su
OX-ST-SU
OX-ST
ST
ox-su
AM-OX-ST-SU-TR
OX
ST-SU
AM-CH-OX-ST-SU-TR
CH-OX-SU-TR
(2)
ox
AM
AM-OX
OX-ST-SU
ST-SU
AM-ST-SU
AM-OX-ST-SU
OX-ST
ST
CH-OX-ST-SU
(3)
OX
ST-SU
OX-ST-SU
AM
AM-ST-SU
ST
CH-ST-SU
OX-ST
AM-CH-KA-OX-SU
OX-SU
(4)
OX-ST
AM-OX-ST
AM-KA-OX-ST
AM-OX
AM-ST
KA-OX-ST
AM-KA
KA-ST
AM-KA-ST
KA-OX
* present study; (2) Linton « a/. [21]; (3) Miller « a/. [25]; (4) Levy « a/.
* For abbreviations, see Table 1
[20]
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CHAPTER V
EFFECT OF ANTIBIOTIC THERAPY ON THE ANTIBIOTIC
RESISTANCE OF FAECAL ESC#E/UC/7M COL/ IN PATIENTS
ATTENDING GENERAL PRACTITIONERS.
N. London, R. Nijsten, P. Mertens, A. van den Bogaard, E. Stobberingh
Journal of Antimicrobial Chemotherapy 1994; 34: 239-246.

SUMMARY
To analyse the influence of antibiotic therapy on the faecal flora of patients from
general practice with complaints of a respiratory tract infection (RTI), 189 paired faecal
specimens were collected, before and after completing antibiotic therapy (n=129) and
symptomatic therapy (n=60). Faecal specimens were examined for the prevalence and
degree of resistance to amoxycillin, apramycin, ciprofloxacin, nalidixic acid, neomycin,
nitrofurantoin, oxytetracycline, sulphamethoxazole and trimethoprim. In the antibiotic-
treatment group a significant increase in the prevalence of resistance to amoxycillin post-
treatment from 50% to 64% (P<0.05, Wilcoxon) was observed. In the symptomatic
treatment group no significant differences in the prevalence of resistance were found.
Using discriminant analysis, amoxycillin and doxycycline therapy contributed to an
increased prevalence of resistance to amoxycillin and oxytetracycline, respectively. In the
antibiotic-treated group £jc/iericWa co/; isolates post-treatment had a significantly increa-
sed resistance rate to amoxycillin (15% - 23%) and to neomycin (2% - 6%) (P<0.05,
Wilcoxon). Logistic regression analysis showed a cross resistance to neomycin and
kanamycin, and for kanamycin cross-resistance to apramycin, neomycin and streptomycin
occurred.
INTRODUCTION
Antimicrobial agents are one of our major resources for the prevention and
therapy of infectious diseases. However, use of antibiotics selects for antibiotic-resistant
strains, for example in the faecal flora [3,14,19]. Most studies dealing with the relation
between antibiotic consumption and antibiotic resistance have been performed in hospitals
and describe a positive correlation between usage and resistance [2,8]. In Finland the
increased resistance of Esc/ieridu'a co/i to trimethoprim from 8% to 35% paralled the
increased consumption of trimethoprim and co-trimoxazole between 1971 and 1984 [7].
Mouton er a/., 1990 [15] found a positive correlation between antibiotic consumption of
flucloxacillin, cephalosporines and gentamicin and prevalence of methicillin-resistant
coagulase negative staphylococci. In contrast, Rosendal « a/., 1977 [17] showed a rapid
decrease in the percentage of methicillin-resistant Srap/iy/ococcitf aurim from 1969 to
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1974, despite an increase in the usage of methicillin. Sometimes a decline in usage of one
compound is not only related to a decreased resistance to that agent but also to a non-
related antibiotic [13]. Only limited data are available on antibiotic resistance in general
practice patients [1,4,20,21]. General practitioners prescribe antimicrobial agents mostly
for the treatment of urinary tract infections (UTI) and respiratory tract infections (RTI).
This study describes the effect of antibiotic treatment of RTI on the antibiotic resistance
of faecal isolates of general practice patients.
MATERIALS AND METHODS
Sample population
During a six-week period, November to December 1992, patients in the south of
the Netherlands, who attended their general practitioner with RTI were requested to
participate in the study. Regardless of the therapy prescribed, they were asked to send in
one faecal specimen before starting therapy and one just after completion treatment. In
addition they were asked to fill in a questionnaire that included questions on the current
therapy prescribed (antibiotic or symptomatic treatment), antibiotic use and/or hospitali-
zation in the previous three months, keeping domestic animals, occupation (slaughter or
stock-farmer or others). Patients were excluded if the first faecal sample was collected
more than 24 hours after start of the therapy. In addition faecal samples had to be
received and processed not more than 48 hours after collection and only those specimens
which showed growth on the agar plates without antibiotics were included in the final
analysis. Other exclusion criteria were antibiotic use and/or hospitalization in the previous
three months.
Specimen collection and processing
One gram of fresh faeces was diluted 1:10 in 0.9%(w/v) NaCl supplemented with
20%(v/v) glycerol and stored at -20°C until assayed. The methods used for the analysis
were as previously described [11]. Briefly, after thawing the suspensions, serial ten-fold
dilutions were made up and 0.037 mL were inoculated on to Levine agar plates (Oxoid
CM 69, Ltd., Basingstoke, England) with and without antibiotics using a spiral plater
(Lameris Laboratorium B. V., Breukelen, the Netherlands). On Levine agar plates
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ridua co// has a purple appearance with a black centre and a green metallic sheen.
The antimicrobial agents and the concentrations used are shown in Table II. The total
number and number of resistant Enterobacteriaceae were recorded after incubation at
37°C for 18-24 hours.
The prevalence of antibiotic-resistance in the faecal specimens tested was defined
as the number of specimens with resistant Enterobacteriaceae divided by the total number
of specimens tested multiplied by 100%. The degree of antibiotic resistance in each
sample was defined as the percentage ratio between the number of colonies grown on the
agarplates with antibiotics and without antibiotics. If the ratio was S50% the degree of
resistance was defined as high, and a ratio between 0% and 50% was defined as low.
From each sample one colony with the colonial morphology of Erc/icncWa co/i was
randomly picked out from the agar plate without antibiotics and tested for indole reaction
and growth at 42 °C. Only isolates yielding positive results for both tests were considered
to be £jc/iericA/a CO/J. Identification was confirmed by random selection of 50
Ercteric/ua cofi using the API 20E system.
Susceptibility tests
The antibiotic susceptibility was determined for all EjcfericWa co7» strains,
isolated from the agar plates without antibiotics, using a microbroth dilution method in
Iso-Sensitest Broth (Oxoid CM 473) and an inoculum of 5x10* CFU/mL. The plates were
incubated for 18-24 hours at 37'C, with the MIC defined as the lowest concentration to
completely inhibit growth. Erc/ieric/i/a co/j ATCC 25922 and ATCC 35218 were used as
reference strains. The breakpoints for resistance of the antimicrobial agents (Table IV)
were those recommended by the guidelines of the Dutch Working Party on Antimicrobial
Susceptibility Testing [9]. For apramycin the breakpoint of resistance was > 16 mg/L [6].
Analysis of the antibiotic susceptibility of the £jc/ieric/i/a co// strains isolated before and
after therapy was performed firstly using percentages of sensitive and resistant strains,
according to these breakpoints, and secondly as a classification of the MIC values into
two categories. This classification is based on the assumption that MIC values within one
doubling-dilution step are considered to be the same. Category I includes strains with the
same MIC value (± one dilution) or a decreased MIC value of more than one dilution,
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and category II includes strains with an increased MIC value of more than one dilution.
Statistics
The chi-square test, Wilcoxon Matched-Pairs test and Mann-Whitney U-test were
used to analyse whether there were significant differences in antibiotic-resistance pre-and
post-treatment. Discriminant analysis was used to analyse the relationship of questionnaire
answers to antibiotic resistance. These were considered to be dichotomised variables.
When analysing resistance to one particular agent, pre- and posttreatment, the prevalences
and degree of resistance to the other agents were also considered as variables. When
analysing the changes in antibiotic resistance of the post-treatment-group, the prevalences
and degree of resistance of all agents from the pre-treatment period were analysed toge-
ther with the other variables. Logistic regression was used to analyse the contribution of
questionnaire answers to the ratio between the categories I and II. The ratios of the other
agents were also considered as variables.
P<0.05 was considered significant.
RESULTS
Sample population
The total number of pre-treatment faecal specimens was 325. Excluded from
further analysis were those patients who used any antibiotics, or were hospitalized in the
previous three months (n=25 and n=2, respectively), or from whom the first faecal
sample was collected more than 24 h after start of the therapy (n = 10). This left 288 pre-
treatment samples, including 91 from symptomatic-treatment patients. Post-treatment 189
faecal specimens were collected, including 60 from symptomatic-treatment patients. Only
paired samples, (n = 189) were included in the final analysis. The majority of the antibio-
tic-treatment patients received amoxycillin (n=68) or doxycycline (n=54). Only six pa-
tients received erythromycin and one co-trimoxazole. As symptomatic therapy mostly
analgesic and mucolytic agents were used. The characteristics of the symptomatic- and the
antibiotic-treatment patients were similar (Table I).
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Table I. Characteristics of the patient population.
symptomatic therapy antibiotic therapy
(n=60) (n=129)
Mean age/range (years) 37.9/2-74 35.3/1-82
Males (n) 29 64
Hospitalization of family member (n) 9 18
Domestic pets (n) 32 68
Slaughterer/stock-fanner (n) 7 3
Prevalence of antibiotic-resistant Enterobacteriaceae
The mean log'°(CFU) of Enterobacteriaceae per gram of faeces, in the specimens
pre- and post-treatment was similar, regardless of the therapy prescribed. For the pre-tre-
atment specimens of the antibiotic-treatment and the symptomatic-treatment groups the
mean log'°(CFU) was 7.60 (range 3.43 - 10.37) and 7.49 (range 4.13 - 10.00), respect-
ively. For the post-treatment specimens the corresponding figures were 7.49 (range 3.43 -
10.12) and 7.40 (range 3.43 - 10.06). As shown in Table II, no significant differences
were observed in the prevalence of resistance to any of the antibiotics tested before and
after symptomatic treatment. In the antibiotic-treated group the prevalence of resistance to
amoxycillin increased significantly (from 50% to 64%, P<0.05, Wilcoxon). The
observed increases in resistance to oxytetracycline and sulphamethoxazole were not
significant. Between the antibiotic-treatment and the symptomatic-treatment group, a
difference in prevalence of resistance to neomycin was observed both pre- and post-
treatment. The increased prevalence of antibiotic resistance post- versus pre-treatment was
related to the antibiotic therapy prescribed (Table III). Amoxycillin therapy contributed
significantly to the increased prevalence of resistance post-treatment not only to amoxycil-
lin but also to oxytetracycline. Similarly, doxycycline therapy resulted in an increased
prevalence of resistance post-treatment to oxytetracycline as well as to amoxycillin.
Using discriminant analysis, antibiotic therapy as well as pre-treatment resistance were
important factors contributing to the resistance post-treatment (data not shown).
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Table II. Prevalence of resistance of the symptomatic-treatment group (n=60) and the
antibiotic-treatment group (n = 129) pre- and post-treatment.
Antibiotic
(mg/L)
AmoxyciUin (25)
Apramycin (32)
Ciprofloxacin (4)
Nalidixic acid (32)
Neomycin (8)
Nitrofurantoin (50)
Oxytetracycline (25)
Sulphamethoxazole (100)
Trimethoprim (8)
Symptomatic-treated group
prevalence
pre
55'
2
0
2
3'
3
37
40
19
post
48
2
0
2
5'
0
43
46
25
Antibiotic-treated group
prevalence
pre
50"
0
0
1
13'
2
38
44
25
post
64'
1
0
2
19*
2
49
52
26
'"P<0.05
Table III. Relation between amoxyciUin / doxycycline therapy and resistance.
Agent
AmoxyciUin
Oxytetra-
cycline
Kind of
therapy
amoxyciUin
doxycycline
amoxyciUin
doxycycline
Pre-/
post-
pre-
post-
pre-
post-
pre-
post-
pre-
post-
Susceplible
34
20
47
44
31
26
33
22
Low
degree
20
29
18
23
21
24
13
19
High
degree
14
19
10
8
9
11
8
13
Number of
patients
68
68
75
75
61
61
54
54
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Susceptibility testing
From eight out of 60 and 13 out of 129 patients no Erc/ieric/uVz CO/J could be isola-
ted either from the first or the second faecal sample, resulting in totals of 52 and 116
Ejcteric/i/a co/i strains, respectively, for susceptibility testing to 12 antimicrobial agents.
As shown in Table IV, for the antibiotic-treatment patients a significant increase in
resistance post-treatment was observed for amoxycillin (from 15% to 23%) and for
neomycin (from 2% to 6%). For the symptomatic-treatment patients a significant increase
in resistance post-treatment was only observed for sulphamethoxazole (19% to 39%).
Table IV. Antibiotic resistance of Erc/ieric/i/a co// isolates from the symptomatic-
treatment group (n=52) and the antibiotic-treatment group (n = 116) to 12 antimicrobial
agents.
Antibiotic Breakpoint Percentages of resistant isolates
symptomatic antibiotic
(mg/L) (n=52) (n = 116)
pre- post- pre- post-
Amoxycillin
Apramycin
Amoxycillin/
clavulanic acid
Chloramphenicol
Kanamycin
Nalidixic acid
Neomycin
Nitrofurantoin
Oxytetracycline
Streptomycin
Sulphamethoxazole
Trimethoprim
16
16
16
8
16
8
16
32
16
16
128
2
6
0
0
2
2
0
2
0
19
17
19*
4
15
0
0
6
2
0
2
2
25
27
39"
8
15"
1
0
3
4
3
2'
0
19
27
27
10
23"
0
0
9
7
2
6"
3
22
28
27
10
'P<0.05
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After antibiotic treatment, the ratio between the number of strains in category I
and II for neomycin and kanamycin was significantly higher than after symptomatic
treatment. For sulphamethoxazole, the opposite was observed (Table V). Logistic
regression analysis showed a positive correlation between the number of strains with an
increase in neomycin resistance and kanamycin resistance (category II), and also between
kanamycin and apramycin, neomycin and streptomycin resistance (data not shown).
Table V. Distribution of strains among the categories I and II (see text) for the sympto-
matic-treated group (n=52) and the antibiotic-treated group (n=116).
Antibiotic
Amoxycillin
Apramycin
Amoxycillin/
clavulanic acid
Chloramphenicol
Kanamycin
Nalidixic acid
Neomycin
Nitrofurantoin
Oxytetracycline
Streptomycin
S ulphamethoxazole
Trimethoprim
Symptomatic-treated
number of strains
in category:
I
43
51
44
48
51
50
49
48
45
44
33
43
II
9
1
8
4
1*
2
3'
4
7
8
19*
9
Antibiotic-treated
number of strains
in category:
I II
99 17
113 3
105 11
108 8
107 9*
109 7
101 15*
106 10
100 16
98 18
90 26'
96 20
•P<0.05
DISCUSSION
The main finding of the present study was the increased prevalence of antibiotic
resistance in patients faecal flora receiving amoxycillin and/or doxycycline therapy for the
treatment of RTT in general practice. In 1991 in the same region, the antibiotic resistance
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of isolates from faecal specimens from healthy volunteers was studied [11]. The preva-
lences of resistance to oxytetracycline, sulphamethoxazole and trimethoprim were similar
to those observed in the present study. The prevalence of resistance to amoxycillin was
higher in the faecal flora of patients in the present study compared with healthy volunteers
(approximately 20% increase). Seasonal variations in antibiotic resistance may occur. The
study with healthy volunteers was performed in spring, and the present one in early
winter. However, in the study of Vorland er a/., 1985 [21] the resistance percentages of
antibiotic-resistant UTI isolates was constant throughout the year. Although in the present
study the prevalence of antibiotic resistance in each group was similar (50% and 55%),
the difference observed was significant. The antibiotic susceptibility of Erc/iericWa co/i
isolates, pre- and post-treatment, was significantly different. For the antibiotic-treated
group, amoxycillin resistance increased from 15% to 23%. Remarkably, for the sympto-
matic-treatment group an increase in resistance to sulphamethoxazole from 19% to 39%
was observed. However, in our previous study of healthy volunteers the frequency of
resistance to sulphamethoxazole ranged from 26.7% to 37.5% [12]. Therefore, we
suggest that the observed increase in resistance is artefactual, reflecting the low prevalen-
ce found pre-treatment. Rosner, 1985 [18] showed that Esc/ieric/i;a co// K-12 strains
become significantly tolerant to chloramphenicol, tetracycline, ampicillin and nalidixic
acid in the presence of chemorepellents such as acetyl sal icy late (aspirin), and that this
occurred regardless of the different modes of action of the antibiotics, and the lack of
relation between the structures of the agents and the chemorepellents. Whether other
analgesic or mucolytic agents can cause an increase in the prevalence of antibiotic resis-
tance needs further study.
Another striking observation was the higher prevalence of resistance to neomycin
in the antibiotic-treatment group pre-and post-treatment (Table II) and the increased
resistance to this agent of the EycTier/cMa eo// isolates (Table IV). In the Netherlands
neomycin is mainly used in veterinary medicine for the treatment of diarrhoea in young
pigs, and the use in human medicine is limited to local treatment with skin ointments.
Although the questionnaire did not include questions about use of such local treatment, it
is not likely that the use in skin ointment could cause the increased resistance to neomycin
of faecal flora. The influence of veterinary antibiotic use on the bacterial resistance in
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humans to antibiotics in general requires further study.
We conclude that in addition to antibiotic therapy pre-treatment, antibiotic
resistance positively contributed to resistance post-treatment. Ongoing surveillance of
antibiotic-resistance in the flora of healthy people should occur, because resistant bacteria
in the community represent the largest reservoir of resistant genes [5], and because of the
correlation between antibiotic-resistance of colonizing and infecting bacteria [10].
Knowledge of the prevalence of antibiotic-resistance provides general practitioners with
essential data for their choice of empiric therapy [16].
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CHAPTER VI
COMPARISON OF VIRULENCE FACTORS OF URINARY AND
FAECAL ESCflEWCtfM COL/ ISOLATED FROM
THE SAME PATIENT
N. London, C. Driessen, A. van den Bogaard, E. Stobberingh
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SUMMARY
The degree of correspondence between urinary and faecal £rc/i£ric/iia co// isolated
from the same individual was assessed in twenty-seven non-pregnant women with urinary
tract infection. Strains were biotyped, analysed for O:K serotypes, hemolysin production,
P fimbriation, transfer of antibiotic resistance, plasmid content, outer membrane protein
profile and presence of the aerobactin iron uptake system.
Cluster analysis revealed similar Enrfenc/ua co// isolates in the corresponding
urine and faecal samples in 18 of 27 patients. Similar plasmid patterns and outer
membrane protein profiles were obtained in 13 and 19 of the combinations tested,
respectively. The genes for both the aerobactin-iron receptor and production were present
in 9 urinary and 8 faecal strains. Resistance to amoxycillin, oxytetracycline, streptomycin
and sulphamethoxazole in various combinations occurred most frequently in both groups
of strains.
01 was mainly associated with Kl antigen and P fimbriation, 02:K? and O6:K2
with P fimbriation and hemolysin production.
The data in this study underscore the importance of the faecal flora as a reservoir
and source of potentially uropathogenic bacteria in women.
INTRODUCTION
Of all Gram-negative bacteraemias £sc/iericft/a co/i accounts for 30 to 45% of
these episodes with an overall mortality of about 33% [25]. Despite the availability of
new antimicrobial agents the mortality did not significantly reduce over the past twenty
years [8]. Since, inadequate therapy will result in an increase in mortality. For optimal
antibiotic therapy knowledge as to the antibiotic susceptibility of the microorganisms to be
expected is essential.
The primary site of infection for Erc/iencWa co/i" bacteraemia is the urinary tract
followed by the gastrointestinal tract [25]. Urinary tract infection (UTI) is the most
common form of extraintestinal EscAeridi/a co// infection in women, and EjctericWa co//
is the pathogen most commonly isolated in UTI [13]. Since the faecal and periurethral
flora are considered to be the reservoir for these bacteria, several studies have been
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performed to examine the correlation between urinary and periurethral EscAcricWa co/i
[2], urethral and faecal Escteridi/a co// [23] or urinary and faecal Eyc/ieric/ua coW
[3,5,18,21,22,29].
Although several studies stressed the importance of the faecal flora as the most
important reservoir of potentially uropathogenic bacteria [10,17], none of them analysed
extensively virulence factors including antibiotic resistance of the uropathogen and the
corresponding faecal isolate of the same patient. In the present study we provide ecidence
as to the similarity between urinary tract and faecal isolates of the same patients using
hierarchical cluster analysis.
MATERIALS AND METHODS
Patients and strains
During a six-week period adult, non-pregnant, female patients presenting to their
general practitioner with either dysuria, stranguria, urinary frequency or urgency in the
past 24 hours were included in the study. Patients were excluded if they had signs and
symptoms of acute pyelonephritis or had known structural abnormalities of the urinary
tract. Patients were also excluded if they had received immunosuppressive drugs or
antibiotics, had been hospitalized or had a known urinary tract infection within the past
three months. In addition to a clean voided urine specimen for standard quantitative and
qualitative bacterial culture patients were asked to send in one faecal sample before
starting antibiotic therapy. Only those patients were included if they had a bacterial
colony count in the urine specimen & 10* CFU/ml of one single species and from whom
a faecal sample was received and processed within 24 hours after receiving the urine
specimen. For isolation and identification of the microorganisms standard bacteriological
methods were used that included the API-20E biochemical system (API System, La Balme
Les Grottes, Montalieu-Vercieu, France). From both urine and faecal sample one
£icAencA/a co/i-like colony was randomly picked out for comparative analysis. The study
was approved by the Ethical Committee of the Maastricht University Hospital. All pa-
tients received oral and written information and all gave informed consent.
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Serotvping of Ercftencft/a co/t
Esc/iemr/iia co// serotyping (for O and K antigens) was performed at the National
Institute for Public Health and Environmental Protection (RIVM), Bilthoven, the
Netherlands on those isolates from patients whose urine and faecal samples yielded
Escteric/wa co//. The O antigens were identified by bacterial agglutination using 170 anti-
0 sera. Non-agglutinating strains were defined as O-nontypeable (ONT), spontaneous
agglutination as SA. Strains without a detectable K-antigen were defined as K-, strains not
agglutinating with any of the antisera related to a specific O group were defined K?
Hemolytic activity
Hemolysin production was determined on nutrient agar plates (Oxoid CM3)
containing 5%(v/v) sheep blood. The presence of a hemolytic zone larger than the
overlaying colony was considered positive.
P Fimbriation
The strains were subcultured twice on colonization factor antigen (CFA) agar
plates [6] to stimulate P fimbriae expression. P fimbriation was assayed by indirect
immunofluorescence with monoclonal antibodies raised against various serotypes of P
fimbriae, i.e. F7,, FT,, F8, F9, F l l , F12 or /w/> (pyelonephritis-associated pilus). The
same monoclonal antibodies were used as in the study of de Ree [27].
Susceptibility testing
The antibiotic susceptibility was determined using a microbroth dilution method in
Iso-Sensitest broth (Oxoid CM 473) and an inoculum of SilO* CFU/ml. After incubation
at 37°C for 18-24 hours the MIC was defined as the lowest concentration that completely
inhibited growth. Erc/ieric/i/a co// ATCC 25922 and ATCC 35218 were used as reference
strains. The breakpoints for resistance were those recommended by the guidelines of the
Dutch Working Party on Antimicrobial Susceptibility Testing [15]. For apramycin the
used breakpoint was > 16 mg/L [12].
Resistance transfer
Broth culture mating was performed using £jcAcric/i/a co// K-12 (nalidixic acid-
resistant) as recipient. In short, overnight cultures of recipient and donor were diluted
1:10 in fresh Brain Heart Infusion broth (Oxoid CM 225) and incubated at 37°C for 2 h.
Then they were mixed in the ratio 1:1 in fresh BHI and incubated at 37°C for another 2
h. Mixtures were inoculated on the surface of Iso-Sensitest agar (Oxoid CM 471) plates
containing nalidixic acid (32 mg/L) and one of the following antibiotics : amoxycillin (32
mg/L), chloramphenicol (32 mg/L), oxytetracycline (32 mg/L), streptomycin (20 mg/L)
or sulphamethoxazole (256 mg/L). The plates were incubated overnight and then exami-
ned for growth. Control experiments were performed with donor or recipient and
0.9%(w/v) NaCl as recipient or donor, respectively.
Plasmid studies
Plasmid profile analysis was done using the method of Kado and Liu [14]. Plasmid
DNA was visualised by staining with ethidium bromide and visualised with ultraviolet
light. As size markers (4.4, 5.8, 7.6, 39 and 91 kb) plasmids isolated from a Sa/monW/a
rypWmuriu/n strain (kindly provided by N.van Leeuwen. the National Institute of Public
Health and Environmental Protection) were used.
Gels were photographed with a Polaroid camera with a red filter using a type 667 Kodak
film.
Characterization of amoxycillin-resistant E?cftf/7'c/»'a co// strains
For all amoxycillin-resistant Erc/ieric/i/a coff strains sonicated extracts from 4h
cultures in Isosensitest broth were used for analytical isoelectric focusing (IEF) using a
pH range of 3-10 and 4-6.5 [26]. £rc/ienc/iia co// strains producing either the TEM-1 or
the TEM-2 B-lactamase were used as reference strains.
Analysis of outer membrane protein profile
Overnight cultures in Iso-Sensitest broth derived from single colonies were
centrifuged (15 min, 6000 £, 4°C), resuspended in 7 ml 50 mM Tris-2 mM EDTA buffer
pH 8.5 and lysed by ultrasonication five times during 20s at 0°C, with a 20s cooling
period between treatments. After centrifugation (20 min, 2000 g, 4°C), the supernatants
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were cleared by centrifugation (60 min, 26500 g, 4 ' C ) , the pellets resuspended in 5 ml 2
mM Tris buffer pH 7.8 + 0.5 ml MgCl, and incubated for 60 min at 4°C. After 15' at
roomtemperature 0.5 ml 20%(v/v) Triton X-100 was added and another 45 min incubated
at the same temperature. Then the suspensions were centrifuged (60 min, 140000 £,
15°C) and the resultant pellet resuspended in 1 ml 2 mM Tris buffer pH 7.8 and stored at
-20°C.
The protein content was estimated by the method of Bio-Rad with bovine serum as
the standard (Bio-Rad Laboratories). For SDS-PAGE analysis, 10 jig protein per sample
was separated in 11% polyacrylamide gels (acrylamide/bisacrylamide ratio 30% / 2.67%)
according to the method of Laemmli [16]. Gels were stained with Coomassie brilliant
blue R-250. As size standards the low molecular weight standards from Bio-Rad (Bio-Rad
Laboratories) were used.
Detection of genes coding for aerobactin production and aerobactin-iron receptor function
The aerobactin biosynthesis probe was a 2 kb /Iva / fragment prepared from
plasmid pABN5 [1] and the aerobactin-iron receptor probe was a 2.3 kb Pvu // fragment
prepared from plasmid pABNl [4], both kindly provided by K.G.Wooldridge. The DNA
probes were purified by extraction with diatoms earth from agarose gels and labeled with
digoxigenin according to the manufacturers instructions (Boehringer Mannheim Bioche-
mica, Mannheim, Germany). The strains were screened by making colony blots on nylon
membranes (Nytran) according to the manufacturers instructions (Nytran, Schleicher &
Schuell, Den Bosch, the Netherlands). As positive controls the strains containing the
plasmids pABN5 and pABNl were used, as negative control EsctericWa co// K-12.
Prehybridization and hybridization were performed under stringent conditions (50%(v/v)
formamide and 5.SSC [1.SSC is 0.15M NaCl plus 0.015M sodium citrate] at 42°C, and
washes in 2.SSC plus 0.1%(w/v) SDS and O.lxSSC plus 0.1%(w/v) SDS at 68°C). The
detection of digoxigenin-labeled nucleic acids was performed by chemoluminescence on
radiographic films (Kodak X Omat AR).
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Statistics
Hierarchical cluster analysis by single linkage and Squared Euclidian distances
(i.e. Distance (X,Y)=E(X;-Yj)') was used to determine the similarity between the urinary
and faecal Erctenc/i/a co//.
RESULTS
During the six-week period 83 female patients presented to their general practitio-
ner with complaints of UTI. Excluded from further analysis were patients who had used
antibiotics (n=8) or had being hospitalized in the previous three months (n=6). From
five patients the faecal sample was not received duly in time. Another 27 women were
excluded because of a colony count of the urine of less than 10* CFU/ml. In nine cases
another species than £jc/!er/c/;ia co// was isolated. In one faecal sample no Erc/ieric/ua
co/i could be isolated and therefore also excluded from further analysis. Finally a total of
27 patients with a bacterial count of 10* CFU/ml ErctericWa co/i in urine specimens and
from whom also a faecal sample was received were studied. The mean age of the patients
was 46.8 years with a range between 17 and 78 years. The characteristics of the £scte-
ricft/a CO/J isolates in the corresponding urine and faecal samples are shown in the Table.
Biotyping of Erd?eric/»'a co//
The API 20E-profile most often found was 5144572, i.e for the urinary and faecal
strains ten-and nine-times, respectively. The same profile was found in 17 of 27 pairs
tested.
O antigens and their association with K antigen
In 19 of 27 urinary isolates O antigen was detectable. O6 was the most common
type (5 of 27), followed by 02 (4 of 27) and 01 (3 of 27). Of the faecal isolates 21 of 27
were O-groupable. The most common types were 01 and 02 (each 3 of 27), both types
were mainly combined with Kl antigen. Spontaneously agglutinating (SA) strains were
found in 5 urinary and 4 faecal strains, respectively. The same combination of O and K
antigens was found in 14 of 27 pairs of urinary and faecal Ejc/ieric/i/a co//.
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ftemolvsin production
Seven urinary and 5 faecal strains were positive, which corresponded with 5 pairs
of isolates. Hemolysin production was most often associated with 06 (6 of 12) and O2 (4
of 12) antigen, respectively.
P fimbriation
Four pairs of urinary and faecal strains were P fimbriated. Serotype F9 was
present in 4 strains (i.e. 2 pairs) and associated with O1:K1 but not with hemolysin
production. The other two serotypes, F12 and F72, found were associated either with
02:K? or O6:K2 and hemolysin production.
Antibiotic resistance
Resistance to amoxycillin, oxytetracycline, streptomycin and sulphamethoxazole in
various combinations occurred most frequently. In total 19 of the 54 strains were resistant
to any (or combinations) of the antibiotics tested. In 12 of these 19 isolates the resistance
was transferable to Esc/ieric/i/a co/;' K-12 (underlined in Table). Resistance to amoxycillin
was in the 8 amoxycillin-resistant isolates due to TEM-1 B-lactamase. Similar antibiotic
resistance patterns were observed in 7 of 27 pairs of urinary and faecal strains, while
susceptibility to all agents tested was found in 16 of 27 pairs.
Plasmid profiles
Similar plasmid profiles were observed in 13 of 27 pairs of isolates. Most profiles
consisted of one or two large plasmids and several smaller ones. No plasmids could be
isolated from 4 urinary and 4 faecal strains, respectively.
Outer membrane protein profile?!
Analysis of the outer membrane proteins (OMPs) yielded 14 different profiles,
which could be distinguished from each other by the various combinations of ten
particular protein bands. Pattern 5 and 8 were observed 15- and 12-times, respectively.
Similar OMPs were observed in 19 of 27 pairs of urinary and faecal strains.
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Aerobactin production and aerobactin-iron receptor
Thirteen urinary EscAeric/ua co// strains possessed the genes for the aerobactin-
iron receptor; another 13 strains the genes for the aerobactin production. In 9 isolates
both kind of genes were present. For the corresponding faecal strains the figures were 11,
11 and 8, respectively. Positive results for both the receptor and the production of aerob-
actin were obtained for S pairs of isolates.
Cluster analysis using all characteristics tested revealed similar Erdieriduo co/i
isolates in the corresponding urine and faecal samples in 18 of 27 combinations tested.
The dendrogram is shown in the Figure.
Figure. Dendrogram: The numbers placed vertically correspond with the pairnumbers
used in the Table. Horizontally the rescaled distance cluster combine is shown.
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Table. Prevalence of virulence
patients.
Source'
r
2
3
4"
5"
6*
r
8"
9'
10"
11"
12"
13
14'
15
U
F
U
F
U
F
U
F
U
F
U
F
U
F
U
F
U
F
U
F
U
F
U
F
U
F
U
F
U
F
API20E
5044552
5044552
5144552
5044152
5044532
5144572
5144572
5144572
5144542
5144552
5044552
5044552
5144512
5144512
5144572
5144572
5144532
5144532
5144572
5144572
5144552
5144552
1044152
1044152
5144572
5044572
5144572
5144572
1044552
5144512
Serotype HA'
O91:K-
O15:K?
O6:K- +
O107:K?
O7:K1
O149:K?
O2:K?
O50:K?
O2:K? +
O2:K? +
O1:K1
O1:K1
O6:K
O126
O2:K?
O2:K1
ONT
ONT
O102:K?
O102:K?
SA
SA
SA
SA
ONT +
SA
O2:K? +
O2:K? +
O18AB:K? -
O74:K-
factors
pp
-
-
-
-
-
-
-
-
-
-
F9
F9
-
-
-
-
-
-
-
-
-
-
-
-
F12
F12
-
in urinary
R-type'
OxSlSu
AmSu"
AmSu
AmChO»SlSu
AmChOxStSu
SlSu
SlSu
and faecal &c/i«ricAi<2 CO/J of 27
Plasmids
(kb)
24
-
-
21,19,3
20,2.8
39.4.6
71,9.1,4.3
71,9.1,4.3
56,3.9
21
20,17,8.7,5.2,4.4
20,17,8.7,5.2,4.4
8.3,4.1
8.3,4.1
71,21,8.7.4.1
71,21,8.7,4.1
71.21,11,9.8,4.8
71,21,11,9.8,4.8
112,39,9.3,5.5
112,39,19,9.3,5.5
18
18
63,8.5,7.6,5,4.4
63,8.5.7.6,5,4.4
14
100,63
63,3.9
63,3.9
100.19,3.6
OMP* Aerobactin
Synt* Rec'
1
1
2 + +
3 - +
4 +
1
5 + +
5 +
6 + +
6 + +
7 + +
7 +
8 - +
8 + +
5 - +
5 + +
9 + +
9 + +
5 +
5 + +
8
8
8 - +
8
9
8
5 + +
5 + +
8
5
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16"
17
18"
19
20
2 1 '
22'
23
24-
25
26'
27-
U
F
U
F
U
F
U
F
U
F
U
F
U
F
U
F
U
F
U
F
U
F
U
F
7144572
5144572
5144572
5144552
5044572
5044572
5044552
5044552
5144572
5144552
5144572
5144572
5144552
5144552
5144152
5144572
5144552
5144552
5144572
1044552
5144572
5144572
4044102
4044102
O14:K?
O14:K?
ONT
08-likc
O11:K-
O11:K-
SA
SA
O6:K-
O22:K13
SA
O135:K?
O6:K2
O6:K2
SA
O25:K-
O1:K1
O1:K1
O150:K-
ONT
O6:K-
O6:K-
O1:K1
O1:K1
-
-
-
-
-
-
-
-
-
-
H F7,
-
-
-
-
F9
F9
AmOxSu
AmOxSu
StSu
St
OxStSu
Am
Am
OxStSu
Ox
Ox
ChOxStSu
ChOxStSu
23,7.9,6.6,4.6,3.1
23,7.9.6.6,4.6,3.1
40.18
18.8.9,4.7
-
16
100.8.3
100,8.3
-
12,6.2
17,6.8
17,6.8
17,2.5
17,2.5
91,50,7.8,4.9,4.6
112
112,6.2
112
71
4.9,4
-
-
50,4.9,4.4
-
9 + +
9 + +
9 +
5
5
5
8 + +
8 - +
10
1
5
5
8 - +
8 - +
11 + -
5
1 + +
1 + +
12
13
1
1
14
14 +
' U = urinary and F = faecal isolate; * HA = hemolysin activity; ' Pf = Serotype of P-
fimbriae; * R-type = Antibiotic resistance pattern : Am=amoxycillin, Ch=chlorampheni-
col, Ox=oxytetracycline, St=streptomycin and Su=sulphamethoxazole, " underlining =
transferable; * OMP = outer membrane protein profile; * Synt=aerobactin production and
Rec= aerobactin-iron receptor
* urinary and faecal sample similar obtained by hierarchical cluster analysis
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DISCUSSION
This study showed the similarity between urinary and faecal EnrfericAia co/i
isolated from the same patient as to the prevalence of virulence factors as well as the
antibiotic resistance tested. Using cluster analysis the majority of the isolates (i.e. 18/27
pairs) was similar for all characteristics tested. In most other studies dealing with the
similarity of urinary and faecal isolates, strains were derived from different patient popu-
lations [9,21] or in the case the urinary and the faecal isolates were derived from the
same patient a limited number of virulence factors were compared, i.e. O-serotyping only
[29]. In the study of Lidin-Janson « a/. [18] more virulence factors were analysed but
only from asymptomatic schoolgirls. In the present study the uropathogens were isolated
from symptomatic UTI in adult female patients and the virulence factors studied included
the presence of the aerobactin system as well as plasmid profiles.
In general the prevalence figures of the virulence factors for the urine and faecal
isolates were quite similar. However some differences did occur. For the uropathogens
the 06-serogroup producing hemolysin was the most prevalent one.Of the K antigens the
combination O1K1, P-fimbriae positive and hemolysin negative was found most frequent-
ly. Similar data were found by Evans « a/. [6] and Hughes « a/. [11]. A relation
between antibiotic resistance and serogroup 08 and 077 was described by Lidin-Janson «
a/.[19]. In contrast, serogroup 0 1 , 02 and 06 as well as Kl antigen were not related to
antibiotic resistance. Also in the present study only three pairs of antibiotic-resistant
urinary and faecal isolates belonged to the 01K1 or 06-serogroup. However, it is known
from other studies that plasmids, i.e. F,me plasmids, can code for both antibiotic resis-
tance and for the production of the hydroxamate siderophore aerobactin, so it is possible
that antibiotic resistance can be present as a result of a plasmid also coding for another
virulence factor [28]. Of the remaining nine combinations the urinary and faecal strains
were distinctly different. This might be explained by the fact that in this study only one
single, randomly selected colony has been used for analysis. Although this single colony
would have represented the dominant biotype in 86% of the specimens, it is to be
expected that testing more colonies would result in a higher percentage of similarity [20].
In the present study the highest prevalence of resistance was found to sulphamet-
hoxazole (urinary and faecal 26%), streptomycin (urinary 22%, faecal 19%), oxytetracy-
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dine (urinary 19%, faecal 22%) and amoxycillin (urinary and faecal 15%). No strains
were found resistant to trimethoprim, nitrofurantoin or nalidixic acid. These percentages
are similar to those we found in a previous study of the antibiotic resistance of faecal
Enr/ieric/ua co// isolated from healthy volunteers living in the same region [24].
According to a recnt study of Eykyn ef a/. [7] episodes of bacteraemia are either
hospital acquired (60%) or community acquired (40%). Although Enterobacteriaceae were
usually hospital acquired, Erc/ieridw'a co/; was considered community acquired in more
than 40%, with as primary site of infections the urinary or the gastrointestinal tract [25].
Thus optimal antibiotic therapy requires data as to the antibiotic resistance of the
microorganism to be expected, especially &c/iencA/a co/i from urine or faecal specimen.
The high similarity between urine and faecal isolates as shown in the present study gives
us the possibility to obtain these data by monitoring antibiotic resistance of faecal isolates.
Therefore ongoing surveillance of antibiotic resistance of faecal isolates is needed [10,17].
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CHAPTER VH
A PIPERACILLIN-TAZOBACTAM RESISTANT ESCJ/E/2/CHL4
C0L7 STRAIN ISOLATED FROM A FAECAL SAMPLE OF A
HEALTHY VOLUNTEER.
N. London, C. J. Thomson, S. G. B. Amyes, E. Stobberingh
(submitted for publication)
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SUMMARY
As part of a surveillance program of the prevalence of antibiotic resistance, the
faecal bacteria of healthy people (n = 1348) were examined and the antibiotic resistance of
the EjcflcricWa eo// strains determined. One strain out of 142 amoxycillin-resistant
isolates, £sc/ieric/ii'a co/i strain 1662, was also resistant to piperacillin-tazobactam but
susceptible to amoxycillin-clavulanic acid. The piperacillin-tazobactam resistance
determinant was transferable to standard Escteridiia co/i strains by conjugation. How-
ever, the strain produced a 0-lactamase with several characteristics very similar to those
of the TEM-1 /3-lactamase, i.e. pi of 5.4, an M, value of 22000 and a comparable
substrate profile. The enzyme was as efficiently inhibited by clavulanic acid and tazobact-
am as the TEM-1 and TEM-2 /3-lactamases but more than the amoxycillin-clavulanic acid-
resistant TRC-1 enzyme. The transferable resistance to piperacillin-tazobactam appears to
be mediated by a novel resistance mechanism that has previously not been described.
INTRODUCTION
Bacterial resistance to /3-lactam antibiotics is due mainly to the production of
/3-lactamases and, by far the most common of the plasmid-mediated enzymes is the TEM-
1 /3-lactamase [6]. In order to overcome the action of these ubiquitous enzymes, 0-lactam-
ase inhibitors, such as clavulanic acid or tazobactam, have been developed and used in
combination with amoxycillin and ticarcillin or piperacillin, respectively [8]. The latter
combination shows particular promise in wro and m vivo, especially with all genera of
the Enterobacteriaceae except Enrerooaaer spp. [4]. Recently some reports mentioned the
isolation of EscnericAia co/i strains with increased resistance to the combinations
amoxycillin-clavulanic acid and/or piperacillin-tazobactam [1,11,12] and, up until now, all
these strains were clinical isolates. In this study some characteristics of an amoxycillin-
clavulanic acid susceptible, piperacillin-tazobactam-resistant faecal £rcn«nc/iia co/i strain,
isolated from a healthy person who had not undergone any antibiotic therapy in the
previous three months, are described. The data are compared to the strain producing the
TRC-1 /3-lactamase, an amoxycillin-clavulanic acid-resistant variant of the TEM-1 enzyme
identified in a clinical isolate [10].
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MATERIALS AND METHODS
As part of a surveillance program investigating the prevalence of antibiotic
resistance in healthy people, ErcfericA/a co// from 1348 faecal specimens were examined
and their antibiotic resistance profiles determined. Amoxycillin resistance was observed in
142 of the strains isolated. Four of these strains were also piperacillin-tazobactam
resistant; however only one of these showed a stable resistance towards that combination
(strain 1662).
Susceptibilities to amoxycillin (AM), amoxycillin/clavulanic acid (XL), piperacillin
(PP) and piperacillin/tazobactam (PTc) were determined by the E-test (AB Biodisk, Solna,
Sweden) both with an inoculum of 0.5 McFarland and 0.5 McFarland 1:100 diluted (i.e.
5x10* CFU/ml). EscAericWa co// ATCC 25922 and Esc/jerrcMa co// ATCC 35218, were
used as reference strains.
The MICs of aminoglycosides, cephalosporines, oxytetracycline, streptomycin,
sulphamethoxazole, tazobactam and trimethoprim were determined by the microdilution
method with an inoculum of 5x10* CFU/ml. The breakpoints for resistance were those
recommended by the guidelines of the Dutch Working Party on Antimicrobial Susceptibil-
ity Testing [3].
Transferability of antibiotic resistance from &cA«ric/i;a co// 1662 to
co// K-12 (nalidixic acid resistant) was tested in broth mating experiments. Transconjuga-
nts were selected on IsoSensitest agar plates containing nalidixic acid (32 mg/L) plus one
of the following antibiotics: amoxycillin (32 mg/L), oxytetracycline (32 mg/L), strepto-
mycin (20 mg/L), sulphamethoxazole (256 mg/L) or trimethoprim (4 mg/L) after 2h
mixed incubation of donors with the recipient strain Escferic/i/a co// K-12, /w/*. Control
experiments were performed with donor or recipient and 0.9%(w/v) NaCl as recipient or
donor, respectively. Co-transfer of piperacillin-tazobactam resistance with amoxycillin
resistance determinant was analysed by replica plating.
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Plasmid DNA from donors and amoxycillin or piperacillin / tazobactam trans-
conjugants was extracted by the method of Kado & Liu [2], separated by agarose gel
electrophoresis and visualised by straining with ethidium bromide and viewing with UV
light
The molecular masses (M,) of the outer membrane proteins of the strains were
determined by SDS-polyacrylamide gel electrophoresis (SDS-PAGE).
Sonicated extracts from 4 hours cultures (with or without prior induction by 1/2
MIC cefoxitin) in IsoSensitest broth were prepared from strain 1662 and from EyctericWa
co/i strains producing the TEM-1, TEM-2 and TRC-1, /3-lactamases. The enzymes were
characterised by analytical isoelectric focusing (IEF) over the pH ranges 3 - 10 and
4 - 6.5 [5]. 0-lactamase activity, substrate profile and the inhibition by clavulanic acid or
tazobactam (ID50, were determined spectrophotometrically. The degree of purity of the
enzymes were analysed both by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and
IEF. Both kind of gels were stained with Coomassie Brilliant Blue (CBB).
RESULTS
Antibiotic susceptibility of Ercftgricfrfa co/f strains
The MICs of amoxycillin (>256 mg/L), piperacillin (>256 mg/L), amoxycillin-
clavulanic acid (8 mg/L), piperacillin-tazobactam (32 mg/L) and tazobactam alone (> 128
mg/L) were determined for EscAericWa co/i strain 1662. The MIC of piperacillin-
tazobactam was determined several times by using the E-test and ranged from 32 mg/L to
128 mg/L with an inoculum of 0.5 McFarland and 0.5 McFarland 1:100 diluted. The
MIC distribution of all 142 amoxycillin-resistant strains is shown in Figure 1. When the
TRC-1 producing strain was examined under the same conditions, MICs of amoxycillin
(>256 mg/L), piperacillin (>16 mg/L), amoxycillin-clavulanic acid (24 mg/L) and
piperacillin-tazobactam (4 mg/L) were found. Both strains remained fully susceptible to
second and third-generation cephalosporins.
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Figure 1. The MIC distribution of all 142 amoxycillin-resistant strains for piperacillin-
tazobactam by using the E-test. 50
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co/i strain 1662 was also resistant to oxytetracycline (MIC >256
mg/L), streptomycin (MIC > 128 mg/L), sulphamethoxazole (MIC > 1024 mg/L) and
trimethoprim (MIC >512 mg/L), but was susceptible to apramycin, neomycin,
kanamycin and gentamicin. Resistance to amoxycillin, streptomycin, sulphamethoxazole
and trimethoprim was transferable to EscftericWa co/i K-12. The transfer frequencies
(Table 1) show that the amoxycillin resistant determinant was not closely linked with
oxytetracycline, streptomycin, sulphamethoxazole and trimethoprim resistance genes and
was thus located on a different plasmid. However, in most cases, transfer of amoxycillin
resistance was accompanied by co-transfer of piperacillin-tazobactam resistance. For these
transconjugants the MIC of amoxycillin was >256 mg/L, piperacillin-tazobactam 32
mg/L and tazobactam alone was > 128 mg/L.
Table 1. Transfer frequencies for Erc/ieric/i/'a co// strain 1662.
Antimicrobial
agent
Amoxycillin
Oxytetracycline
Streptomycin
Sulphamethoxazole
Trimethoprim
Selecting concentration
(mg/L)
32
32
20
256
4
Transfer frequency
per donor cell
5.4,10'
0
4.6,10^
1.9.10*
5.2x10^
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The plasmid profiles of Eic/iencA/a co// 1662 and its transconjugants together with
the strains producing the TEM-1, TEM-2 and TRC-1 jS-lactamases, respectively, are
shown in Figure 2.
Figure 2. Plasmids in the strains producing TEM-1 (a), TEM-2 (b), TRC-1 (c), Ercteri-
ctoa co/j strain 1662 (d), EjcfericWa co// K-12 amoxycillin transconjugant (e) and
Erc/ieric/i/a co// K-12 piperacillin-tazobactam transconjugant (f). As molecular weight
standards plasmids of 91, 39, 7.8, 5.6 and 4.4 kb from 5a/mon«//a rypAimuriu/n ST13 (g)
were used. Strains were grown in Luria broth and analysed in 0.7% agarose gels.
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Characteristics of fl-lactamase
The jS-lactamases produced by EsdiericWa co// strain 1662 and its transconjugants
were not inducible, had a similar specific activity towards nitrocephin (Table 2) and
focused at pi 5.4, similar to the TEM-1 0-lactamase. The substrate profiles of the
enzymes from strain 1662, TEM-1 and TEM-2 are shown in table 3. No hydrolysis of
cefazolin, cefipime, cefotaxime, cefoxitin, ceftazidime, ceftriaxone, cefuroxime, aztreon-
am and imipenem was detected by spectrophotometric assay.
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Table 2. Specific activities (nmol nitrocephin hydrolysed/min/mg protein) of B-lactamases
1662, TEM-1, TEM-2 and TRC-1.
B-lactamase Specific activity
1662
TEM-1
TEM-2
TRC-1
3110
2210
9270
1800
Table 3. 'Relative rates of hydrolysis (%) of B-lactamases 1662, TEM-1 and TEM-2.
B-Lactam substrate 1662 TEM-1 TEM-2
Nitrocephin*
Penicillin
Amoxycillin
Piperacillin
Ticarcillin
Cephaloridine
100
> 100
37
33
58
17
100
> 100
26
37
100
7
100
> 100
27
52
56
18
' Rate for nitrocephin = 100%
The concentrations of clavulanic acid and tazobactam required to inhibit enzyme
activity by 50% (ID50) were quite similar for the 1662 enzyme and TEM-1, TEM-2.
These concentrations were distinctly lower than those required for the inhibition of the
TRC-1 enzyme (Table 4).
Table 4. Inhibitory dose Qig/L) of clavulanic acid and tazobactam required to inhibit
enzyme activity by 50% GD50) when nitrocephin was used as the substrate.
Inhibitor 1662 TEM-1 TEM-2 TRC-1
Clavulanic acid 16-32 16-32 32 256-512
Tazobactam 1-2 1-2 2 16-32
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The molecular mass of the 0-lactamase was estimated by Nalive-PAGE to be
approximately 22,000, similar to that of the TEM-1 enzyme. There were no visual
differences in major outer membrane protein profile between Ercteric/i/a co// strains 1662
and its transconjugants and the Esc/ier/cA/a co// strains producing the TEM-1, TEM-2 or
TRC-1 /3-lactamases (Figure 3).
Figure 3. SDS-polyacrylamide gel electrophoresis patterns of cell envelopes of the strains
producing TRC-1 (b), TEM-2 (c), TEM-1 (d), Erc/icnc/ua co// K-12 piperacillin-
tazobactam transconjugant (e), Esc/ieric/i/a co// K-12 amoxicillin transconjugant (0 and
£sc/ieric/»'a co// strain 1662 (g). In lane (a) molecular weight standards, i.e. 97.4, 66.2,
45 and 31 kD are shown. 11% gel.
B
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DISCUSSION
The piperacillin-tazobactam resistant £rc/iencA/a co// strain described in this study
was isolated from a faecal sample of a healthy person who had not taken any antibiotics
in the previous three months before sampling. The piperacillin-resistant determinant was
usually co-transferable with the amoxycillin resistance gene. The /3-lactamases produced
by strain 1662 and its transconjugants were indistinguishable from the TEM-1 /3-lactamase
for all characteristics tested. Remarkably the 0-lactamase from strain 1662 was as effi-
ciently inhibited by clavulanic acid and tazobactam as the TEM-1 enzyme. However, the
MIC of piperacillin-tazobactam for the original strain and its transconjugants is & 32
mg/L and both had a high MIC of tazobactam on its own.
Besides alterations in the /3-lactamase produced by the cell [10], resistance to the
combinations of /3-lactams with j3-lactamase inhibitors has previously been explained
either as a result of hyperproduction of the /3-lactamase [9] or as a decrease in the per-
meablility of the inhibitor through the bacterial outer membrane, i.e. absence of porin
OmpF, [7]. Unless the alterations in the 0-lactamase are very subtle and cannot be
detected by convention assays, the results presented here suggest that this is unlikely to be
the mechanism of resistance. Hyperproduction of the /3-lactamase is not very likely
because the specific 0-lactamase activity of strain 1662 is similar to that of TEM-1 and it
was not inducible. Decrease in cell wall permeability would also have been considered to
be an unlikely candidate because the susceptibility of Esc/jeric/«'tf co/i 1662 to several
antibiotics such as the aminoglycosides is similar to that of the strain producing TEM-1.
Furthermore the major outer membrane protein profile is similar for all strains tested.
However, the resistance determinant is transferable and it is possible that an efflux system
is operating which exports tazobactam out of the cell. This view could be supported by
the high MICs of tazobactam alone in both the original stain and its transconjugant and
the absence of any decrease in tazobactam binding, compared with the TEM-1 enzyme, to
the only B-lactamase detected in the cells.
Since this strain was isolated from the faecal flora of a healthy person, not
undergoing antibiotic therapy, this flora could be an important reservoir for the dissemi-
nation of this and similar novel resistance mechanisms as newer agents, especially
containing /3-lactamase inhibitors, are introduced.
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GENERAL DISCUSSION
This thesis describes the prevalence and degree of antibiotic resistance in healthy
humans, i.e. pig farmers, abattoir workers and (sub)urban residents and, in particular,
discusses the reproducibility of sampling and the intra-individual variation in resistance
over time. Attention has been paid to the effect of antimicrobial chemotherapy on the
prevalence of antibiotic resistance in the faecal flora of general practice patients. Evidence
was provided as to the usefulness of monitoring antibiotic resistance of faecal EjcftfricMo
co// to predict antibiotic resistance of uropathogenic £rc/i€ric/ua co//' in primary health
care patients. The mechanisms of resistance of a faecal Ercfteric/i/a co// strain resistant to
the recently introduced combination of piperacillin and tazobactam, and isolated from a
healthy individual not using any antibiotic therapy in the previous three months, were
analysed.
Prevalence of antibiotic resistance in healthy humans
The highest prevalence of antibiotic resistance in the faecal samples of three
populations of healthy volunteers studied was found for the pig fanners, the lowest for the
(sub)urban residents. No significant differences in high degree of resistance to any of the
antimicrobial agents tested were found, except for neomycin which was highest for the
pig fanners.
The variations observed in the prevalence and the degree of resistance in faecal
samples per individual over time could be explained by biological variation (i.e. ±1 .25
'log CFU) and measurement error variation (i.e. 0.5 'log CFU). The high degree of
antibiotic resistance per individual was rather constant over time, but more variation was
observed for the low degree of resistance.
The small variation in antibiotic resistance holds true not only for the high degree
of resistance but also for the antibiotic resistance pattern of the faecal Erc/ieric/i/fl co//'
isolates. In Chapter IV the antibiotic susceptibility of 1348 faecal Erdieric/i/a co// isolated
during the 15-week period, was determined. The majority of the isolates per individual
had only one or two different antibiotic resistance patterns, with a maximum of five. The
number of different patterns was independent of the number of strains per individual.
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The prevalences of antibiotic resistance in the faecal samples of both abattoir
workers and (sub)urban residents were of the same order of magnitude. Higher preva-
lence percentages were found for the pig farmers. Although pig fanners and abattoir
workers do have regular contact with pigs/carcasses and pig faeces, this factor is of minor
importance as no significant differences are observed between these abattoir workers who
have intensive contact and these in whom the contact is less intensive. Eight percent of
the abattoir workers and 5 % of the pig farmers mentioned personal antibiotic consumption
recently, whereas none of the (sub)urban residents mentioned this. However, this
antibiotic usage could not explain the differences found between the three populations. It
is believed that exposure to low concentrations of antibiotics used in animal feed and for
therapy of pigs is the most important factor for the higher percentages found in the pig
farmers.
A wide range of prevalence percentages were found when the results of the 15-
week follow-up study were compared with earlier studies performed in the Netherlands.
The high degree of resistance (S50% of £jc/icric/iia co/i resistant) showed less variation,
as shown in the Table.
In comparing these data one has to take into account that the studies mentioned did
not all use the same methodology. Although Degener « a/. [6] used a higher selective
concentration for ampicillin (40 mg/L) and tetracycline (30 mg/L) and a semi-quantitative
method for determining the numbers of resistant Esc/ieric/i/a co/i, the percentages found
for the prevalence and high degree of resistance were quite similar to those found in the
present study.
In the studies of Bonten « a/ [2,3] and our own studies the same methods and the
same concentrations were used, and only the populations studied were different. The
prevalences and degrees of resistance found, however, were quite different. These data
suggest that several other factors such as differences in overall use of antibiotics in the
populations studied and socio-economic variations are of influence.
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Table. Comparison of % Prevalence (% High Degree) of resistant Esrtericfa'a co// from
different studies in the Netherlands.
study/year
(city) tmoxycillin
mg/L P H.D
oxytetracycline
mg/L P H.D
sulphamethoxazole
mg/L P H.D
DegenerV 1978-80
(Zoetermeer)
Degenei*/1987
(Zoetenneer)
Bonten'/1990
(Maastricht)
Bonten'/1992
(Maastricht)
Bonten'/1992
(Zwolle)
London/1993
(Weert)
London/1993
(Roennond)
40 25 5
40 27 11
25 76 8
25 62 12
25 89 13
25 28±12 7±5
25 33±12 9±5
30 42 12
30 20 6
25 47 11
25 68 21
25 49 14
100 45 19
100 46 21
100 86 37
100 71 19
100 49 15
25 25±7 3±3 100 28±10 8±4
25 31±7 5±4 100 41±7 14±4
A high degree of resistance means that the majority (2:50%) of the isolated faecal
co// are (multi-)resistant. About 10* to 10* £rcA«ric/i;a co/» are generally
found per gram of human faeces. Given about 100 grams of faeces produced daily per
person, an individual with a high degree of resistance to an antimicrobial agent excretes at
least 5.10' to 5x10' resistant bacteria per day. Therefore such people represent a large
source of resistant bacteria and resistance genes [9].
Persons with a low degree of resistance are important as well. Shortly after an
antimicrobial agent for which resistant Erc/iericWa co//' are present in the gastrointestinal
tract has been taken, the resistant bacteria will be selected and excreted in high numbers.
Moreover, both groups of humans have more chance of an infection caused by resistant
microorganisms in the future [8].
The small variations in resistance patterns in each individual as found in our study
are in contrast with those found by Levy er a/. [9] who observed that 90% of all
117
individuals showed a gain (47.6%) and/or a loss (65.7%) of one or more detectable
resistances. However, his findings were based upon the two first faecal samples per
individual while in our study one to 13 samples per individual were analysed during a 15-
week period. Consequently testing more than two faecal samples per individual is, as
expected, more accurate than testing only two samples.
Effect of antibiotic therapy on antibiotic resistance
The data in chapter V demonstrate that amoxycillin and/or doxycycline therapy
results in an increase in prevalence of resistance post-treatment to oxytetracycline as well
as amoxycillin in faecal Erc7ieric7i/a a>//'. These data are in line with those from other stu-
dies showing that antimicrobial agents can select for antibiotic-resistant strains, especially
in the faecal flora [5,7,11].
As the faecal flora is considered to be the reservoir and source not only of potenti-
ally pathogenic bacteria, but also of resistance genes, data concerning the antibiotic
resistance of the faecal EsdiericA/a co// will predict the antibiotic resistance of these
potentially pathogenic microorganisms and will provide essential information for effective
empirical therapy.
Chapter VII describes the isolation and characterization of a faecal isolate
(EjcAeric/i/a co// 1662) resistant to a recently introduced antimicrobial agent, i.e.
piperacillin-tazobactam. The strain was isolated from a healthy person who had not
received any antibiotics in the previous three months. Until then, piperacillin-tazobactam-
resistant strains were either /n vi/ro isolated mutants or in a few cases clinical isolates.
The mechanism of resistance of Erc/icricA/a co// strain 1662 seems to be different from
other piperacillin-tazobactam-resistant strains as isolated so far.
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GENERAL CONCLUSIONS AND RECOMMENDATIONS
In the past IS years in the Netherlands several studies have been performed
regarding the prevalence and degree of antibiotic resistance of faecal Escteric/ua co/i in
healthy humans. The differences observed in the studies performed could be explained
only in part by differences in methodology and it is very likely that differences in the
populations studied have contributed to the observed variation. Differences in the
population include differences in socio-economic circumstances as well as differences in
direct (i.e. personal) antibiotic usage and indirect antibiotic usage (i.e. antibiotic usage in
the population, degree of direct exposure to antibiotics, e.g. in animal feeds, to animals
and animal waste or products).
In general, no steady increase in antibiotic resistance in the open Dutch population
in the past decade has been observed. These data are in line with a survey of nearly one
million hospital isolates in the New York area collected over a 10-year period which did
not show any increase in resistance over time [1]. The authors stated that although local
outbreaks with multi-resistant microorganisms do occur the overall situation is not too
worrying.
It should be a public health goal that a low level of carriage of antibiotic-resistant
strains is maintained in the near future [8,10]. To achieve this active surveillance of
antibiotic resistance of extramural isolates has to be performed. These include establish-
ment of national monitoring stations, which at regular intervals collect a sufficient number
of strains from healthy persons to study antibiotic susceptibilities [4] and antibiotic
resistance patterns as well as the mechanisms of antibiotic resistance.
Knowledge of the prevalence and degree of resistance present in the bacterial flora
of the healthy human population will provide general practitioners with essential data for
their choice of empirical therapy and could alert them to optimalize their prescribing
practices.
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SUMMARY
Emergence of antibiotic-resistant microorganisms continues to be an important
problem for the treatment of bacterial infections. There is general agreement that
antibiotic use in general medical practice and in veterinary medicine is responsible in part
for the development and selection of antibiotic-resistant bacteria. However, it is still not
clear whether antibiotic use in humans or animals has contributed most to the environ-
mental pool of resistant microorganisms.
Up to now many studies have examined the prevalence of antibiotic resistance in
hospitalized patients. In contrast, less information is available on the incidence of
antibiotic resistance outside the hospital. In general, the faecal flora is considered the
most important reservoir of antibiotic-resistant microorganisms. However, in the
Netherlands no recent data are available about the prevalence of antibiotic-resistant
bacteria in the faecal flora of non-hospitalized patients. Therefore, several studies
analysing the prevalence of antibiotic-resistant faecal Esc/ienc/i/a co/; of healthy volun-
teers and of patients from general practice with complaints of an urinary tract infection or
a respiratory infection are presented in this thesis.
In chapter I, after a short introduction, a review of the literature concerning the
prevalence of antibiotic-resistant microorganisms in different populations, i.e. pig
farmers, abattoir workers and general practice patients is given. Furthermore the effect of
antibiotic therapy on the selection of antibiotic-resistant bacteria from human and animal
origin is described as well as possible routes (contact, foodchain) by which these animal
bacteria can reach man and may cause resistance are discussed. Finally the prevalence of
antibiotic resistance in humans outside the hospital, i.e. general practice patients and
(sub)urban residents, is presented. As described in several studies the prevalence
percentages observed are strongly influenced by the method used also data concerning the
high degree of resistance, i.e. the proportion of faecal samples with a ratio S 50%, thus
the majority of the faecal £jc/iericA/fl cort showing resistance to that agent, are given.
In chapter II the prevalence of antibiotic resistance in three populations, i.e. pig
farmers, abattoir workers and as a control group (sub)urban residents, all living in the
same region in the South of the Netherlands, is described. The highest prevalence
percentages were found for the pig farmers, indeed, for amoxycillin, neomycin,
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oxytetracycline, sulphamethoxazole and trimethoprim significantly higher percentages than
for the abattoir workers and (sub)urban residents were found. It was quite remarkable that
only the high degree of resistance to neomycin significantly differed for the three
populations tested, which was again highest for the pig farmers. The differences in
prevalence of resistance observed between pig fanners and abattoir workers could not be
explained by their (intensive) contact with pigs only. Also personal antibiotic consump-
tion, 5% for the pig farmers and 8% for the abattoir workers, could not explain the
differences found between the three populations. It is to be expected that direct contact
with antibiotic-supplemented pig feed, i.e. mass medication, is an important factor for the
higher percentages found in the pig farmers.
Chapter III describes the individual variation regarding the presence of antibiotic
resistance over time. The same group of individuals, already described in chapter II, were
followed up during a 15-week period and their faecal samples analysed weekly. The high
degree of resistance to an antimicrobial agent was more or less constant over time.
Another striking observation were the significant differences in resistance found between
individuals living in the regions Weert and Roermond, of which the last group showed a
higher prevalence and degree of resistance to some of the agents tested compared to the
first group. Although on one hand these results emphasize regional differences in
prevalence of antibiotic resistance, it was on the other hand quite remarkable that these
differences already occurred within such a short distance of 30 km.
The small individual variation in antibiotic resistance was confirmed by the
relatively small number of antibiotic resistance patterns per individual as found in the
faecal Esc/ieric/w'a co/i strains (chapter IV). The faecal £sc/ienc/i/'a co//' from 51 out of the
183 individuals studied showed only one antibiotic resistance pattern, from 63 individuals
two patterns were found. The resistance patterns most frequently observed were resistance
to sulphamethoxazole alone, followed by resistance to sulphamethoxazole in combination
with oxytetracycline and/or streptomycin.
There is general agreement that antibiotic use is an important risk factor for
selection of antibiotic-resistant bacteria not only to the agent used but also to other
(un)related agents. Chapter V describes the effect of antibiotic therapy on the antibiotic
resistance of faecal EsdiericA/a co// from patients attending their general practitioners
with complaints of a respiratory tract infection. Amoxycillin and doxycycline therapy
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Summary
resulted in an increased prevalence of faecal £jc/iench/a co/j resistant to both agents.
The faecal flora is not only considered to be the reservoir for antibiotic-resistant
Esc/ieric/ua co/i but also for uropathogenic Erc/iencWa co//. This last item is elucidated
in chapter VI in which 27 paired isolates from faeces and urine were analysed. Based on
data concerning several virulence factors including hemolytic activity, P fimbriation and
aerobactin production an overall degree of correspondence between urine and faecal
EscAericWa co/i could be shown in 66% of the patients.
In chapter VII the mechanism of resistance against a recently introduced combina-
tion of a B-lactam antibiotic, piperacillin and a B-lactamase inhibitor, tazobactam, is
analysed. It was quite remarkable that the piperacillin/tazobactam-resistant Ejc/zcn'cA/a
co/( was isolated from a healthy person who had not undergone any antibiotic therapy
recently. Up until now, all piperacillin/tazobactam-resistant strains were clinical isolates.
In the concluding chapter (chapter VIII) recommendations are made as mentioned
in this summary. It is strongly recommended to establish monitoring stations to analyse at
regular intervals antibiotic susceptibilities of faecal isolates from non-hospitalized patients
in order to provide essential data for a correct choice of empiric therapy.
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SAMENVATTING
Het voorkomen van antibiotica-resistente microorganismen vormt nog steeds een
belangrijk probleem bij de behandeling van bacteriele infecties. Algemeen wordt aangeno-
men dat het (dier)geneeskundig gebruik van antibiotica bijdraagt aan de ontwikkeling en
selectie van antibiotica-resistente bacterien. Het is echter nog steeds niet duidelijk of het
gebruik in de geneeskunde of juist in de diergeneeskunde het meest heeft bijgedragen aan
de omvang van het resistentie probleem.
Tot nu toe is veel onderzoek beschreven betreffende het voorkomen van antibiotica
resistentie bij patienten in ziekenhuizen. Daarentegen is nog relatief weinig bekend over
het resistentie probleem buiten het ziekenhuis. Algemeen wordt de faeces beschouwd als
het reservoir van antibiotica-resistente microorganismen. Echter recente gegevens
betreffende het voorkomen van antibiotica-resistente bacterien in de faeces van personen
buiten het ziekenhuis zijn in Nederland niet voorhanden. In dit proefschrift worden de
resultaten van faecesonderzoek betreffende de antibiotica-resistente faecale Erc/ieridiia
co// bij gezonde vrijwilligers en bij patienten welke de huisarts bezoeken met klachten van
een urineweginfectie of een luchtweginfectie beschreven.
In het eerste hoofdstuk wordt, na een korte inleiding, een overzicht van de
literatuur gegeven met betrekking tot het voorkomen van antibiotica-resistente microSrga-
nismen in diverse groepen personen, zoals varkenshouders, slachthuispersoneel en
huisartspatienten. Vervolgens wordt het effect van het antibioticagebruik op selectie van
antibiotica-resistente bacterien bij mens en dier beschreven en worden de mogelijkheden
bediscussieerd (contact, voedselketen) hoe de bij dieren aanwezige resistentie kan leiden
tot antibiotica resistentie bij de mens.
Tenslotte wordt het voorkomen van antibiotica resistentie bij personen buiten het
ziekenhuis besproken, te weten bij patienten welke een huisarts bezoeken en bij stedelin-
gen. Aangezien de prevalentiepercentages sterk afhankelijk zijn van de gehanteerde
methode worden ook gegevens vermeld betreffende de hoge mate van resistentie, dat wil
zeggen het percentage van de onderzochte personen waarvan het merendeel (&50%) van
de faecale flora resistent is tegen het onderzochte antibioticum.
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In hoofdstuk 2 worden de prevalenties van antibiotica-resistentie in drie verschil-
lende populaties, te weten varkenshouders, slachthuispersoneel en gezonde stedelingen,
alien afkomstig uit de regio Weert en Roermond, beschreven. De hoogste prevalentie-
percentages werden bij varkenshouders vastgesteld, welke voor amoxycilline, neomycine,
oxytetracycline, sulphamethoxazole en trimethoprim significant hoger waren dan bij
slachthuispersoneel en stedelingen. Opvallend was dat ten aanzien van de hoge mate van
resistentie alleen die voor neomycine significant verschilde tussen de drie populaties.
Deze was het hoogst voor de varkenshouders. Het verschil in antibiotica resistentie tussen
de varkenshouders en het slachthuispersoneel kon niet alleen verklaard worden door het
(intensieve) contact met varkens. Het eigen antibioticumgebruik, bij de varkenshouders
5% en het slachthuispersoneel 8%, kon ook niet de verschillen tussen de drie populaties
verklaren. Het wordt aangenomen dat het contact met antibioticum-gesupplementeerd
varkensvoer een belangrijke rol speelt bij de hogere prevalentiepercentages bij de
varkenshouders.
Hoofdstuk 3 beschrijft de individuele variatie in antibiotica resistentie in de tijd.
Van de in hoofdstuk 2 beschreven groep gezonde personen werden gedurende 15 weken
faecale monsters geanalyseerd. De hoge mate van resistentie tegen een bepaald antibioti-
cum vertoonde weinig variatie tijdens de periode van onderzoek. Opvallend waren de
significante verschillen waargenomen tussen de regio's Weert en Roermond, waarbij
Roermond een hogere prevalence en mate van resistentie vertoonde dan Weert. Hoewel
enerzijds deze resultaten regionale verschillen in antibiotica resistentie benadrukken is het
opvallend dat ook binnen een afstand van ± 30 km reeds verschillen waarneembaar zijn.
De geringe individuele variatie in antibiotica resistentie bleek ook uit het relatief
beperkte aantal resistentie patronen van de faecale Esc/ierictoa co/j per individu (hoofd-
stuk 4). Van de 183 onderzochte personen vertoonden de £jc/ieric/i/a co/i isolaten van 51
van hen e^nzelfde antibioticum resistentie patroon, bij 63 personen werden twee patronen
vastgesteld. De meest voorkomende resistentie betrof resistentie tegen sulfamethoxazole
alleen, gevolgd door resistentie tegen sulfamethoxazole in combinatie met oxytetracycline
en streptomycine.
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Algemeen wordt aangenomen dat gebruik van antibiotics een belangrijke risicofac-
tor is voor de selectie van bacterien resistent tegen het gebruikte middel maar mogelijk
ook tegen (niet-)verwante antibiotica. Hoofdstuk S beschrijft het effect van antibioticum
therapie in de eerste lijn bij patienten met klachten van een luchtweginfectie op het
voorkomen van antibiotica-resistente faecale Erc/iericWa co/i. Amoxycilline en doxycycli-
ne therapie leidde tot een toename in percentage Esc/ieric/i/a co/i resistent tegen beide
antibiotica.
De faecale flora wordt niet alleen beschouwd als reservoir voor antibiotica-
resistente Erc/ieridua co// maar ook als reservoir voor uropathogene Erc/iencMa eo//. Dit
laatste aspect wordt in hoofdstuk 6 nader toegelicht aan de hand van 27 gepaarde isolaten
van faeces en urine. Op basis van verschillende virulentiefactoren zoals hemolytische
activiteit, P-fimbriae en aerobactine-produktie kon bij 66% van de patienten overeenkomst
tussen faecale en uropathogene £rdieridi/a co/; worden vastgesteld.
In hoofdstuk 7 wordt het mechanisme van resistentie tegen een recent geintro-
duceerde combinatie van een B-lactam antibioticum, piperacilline en een B-lactamase
remmer, tazobactam nader geanalyseerd. Opvallend was dat de piperacilline-tazobactam
resistente Esc/ieric/i/a co/i geisoleerd was bij een persoon die vermeldde recent geen
antibioticum gebruikt te hebben. De tot nu toe beschreven piperacilline/tazobactam
resistente isolaten waren alien klinische isolaten.
Tenslotte worden in hoofdstuk 8 aanbevelingen gedaan voor een continue monito-
ring van antibiotica resistentie in de niet-ziekenhuis populatie.
Gepleit wordt regelmatig vast te stellen het resistentie niveau in de open populatie via
resistentie peilstations om zodoende een bijdrage te kunnen leveren aan een juiste keuze
van empirische therapie.
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CURRICULUM VITAE
De schrijfster van dit proefschrift is op 19 februari 1968 in Maastricht geboren. In
1986 behaalde zij het Atheneum B diploma aan het Stedelijk Lyceum te Maastricht. In
hetzelfde jaar begon zij aan de HLO-biochemie opleiding aan de Hogeschool Heerlen te
Sittard. In 1990 behaalde zij haar examen en kreeg ze een baan bij de vakgroep Medische
Microbiologie. Vanaf September 1991 werkte ze aan het onderzoek, dat in dit proefschrift
beschreven is.
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